var title_f16_40_17024="Pelvic lymphadenectomy8";
var content_f16_40_17024=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67137&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67137&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Removal of lymph nodes through 12 mm supra- pubic port",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 370px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ken Hatch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17024=[""].join("\n");
var outline_f16_40_17024=null;
var title_f16_40_17025="Lateral elbow ligaments";
var content_f16_40_17025=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62086&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lateral elbow ligaments",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 422px; height: 303px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The lateral (radial) collateral ligamentous complex stabilizes the elbow against varus forces and maintains the orientation of the elbow bones. It is composed of the radial collateral, lateral ulnar collateral, accessory collateral, and the annular ligaments. The lateral ulnar collateral ligament is the primary lateral stabilizer of the elbow.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from DeLee, JC, Drez, D (Eds). Orthopaedic sports medicine: Principles and practice, W.B. Saunders, Philadelphia 1994. Copyright &copy; 1994 W.B. Saunders.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17025=[""].join("\n");
var outline_f16_40_17025=null;
var title_f16_40_17026="Acanthosis nigricans on neck";
var content_f16_40_17026=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acanthosis nigricans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 410px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A velvety, slightly verrucous plaque is present on the neck.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17026=[""].join("\n");
var outline_f16_40_17026=null;
var title_f16_40_17027="Positioning for puncture of hip joint";
var content_f16_40_17027=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F60186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F60186&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Positioning for ultrasound-guided puncture of hip joint",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient and needle positioning for puncture of hip joint.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Introductory Guide to Musculoskeletal Ultrasound for the Rheumatologist, Second Edition. ISBN 978-90-313-9206-3; Bohn Stafleu van Loghum, Houten 2012. Copyright &copy; 2012.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17027=[""].join("\n");
var outline_f16_40_17027=null;
var title_f16_40_17028="Cefdinir: Patient drug information";
var content_f16_40_17028=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Cefdinir: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/21/5461?source=see_link\">",
"     see \"Cefdinir: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/2/6181?source=see_link\">",
"     see \"Cefdinir: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F147178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Omnicef&reg; [DSC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701737",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to cefdinir or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696844",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids, iron, or multivitamins that have iron within 2 hours of using this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015469\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store capsules at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699460",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (suspension) at room temperature. Throw away any part not used after 10 days.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015471\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11830 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-259ED97FEC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17028=[""].join("\n");
var outline_f16_40_17028=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147178\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015462\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015461\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015466\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015467\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015469\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015464\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015465\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015470\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015471\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/21/5461?source=related_link\">",
"      Cefdinir: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/2/6181?source=related_link\">",
"      Cefdinir: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_40_17029="Leish bone marrow biopsy";
var content_f16_40_17029=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52344&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52344&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 506px\">",
"   <div class=\"ttl\">",
"    Leishmania amastigotes in bone marrow biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 486px; height: 245px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Leishmania amastigotes in bone marrow biopsy specimens from patients with visceral leishmaniasis. Note the nucleus and kinetoplast in each amastigote.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17029=[""].join("\n");
var outline_f16_40_17029=null;
var title_f16_40_17030="Hematopoietic cell transplantation for Diamond-Blackfan anemia and the myelodysplastic syndromes in children";
var content_f16_40_17030=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hematopoietic cell transplantation for Diamond-Blackfan anemia and the myelodysplastic syndromes in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17030/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17030/contributors\">",
"     Shakila Khan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17030/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17030/contributors\">",
"     Donald H Mahoney, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17030/contributors\">",
"     Robert S Negrin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17030/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17030/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/40/17030/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematopoietic cell transplantation (HCT) is an accepted form of treatment for various hematologic disorders in children, such as aplastic anemia and beta thalassemia major. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/50/18217?source=see_link\">",
"     \"Hematopoietic cell transplantation in aplastic anemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11562?source=see_link\">",
"     \"Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5529?source=see_link\">",
"     \"Efficacy of hematopoietic cell transplantation in beta thalassemia major\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use in other hematologic disorders is not as well established. This topic review discusses the use of HCT in two pediatric disorders: Diamond-Blackfan anemia and the myelodysplastic syndromes. The use of HCT in patients with sickle cell anemia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30775?source=see_link\">",
"     \"Hematopoietic cell transplantation in sickle cell disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The term \"hematopoietic cell transplantation\" (HCT) will be used throughout this review as a general term to cover transplantation of progenitor cells from any source (eg, bone marrow, peripheral blood, cord blood). Otherwise, the source of such cells will be specified (eg, autologous peripheral blood progenitor cell transplantation). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38682?source=see_link\">",
"     \"Sources of hematopoietic stem cells\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAMOND-BLACKFAN ANEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diamond-Blackfan anemia (DBA) is a rare congenital hypoplastic anemia that usually presents early in infancy. It is characterized by macrocytic anemia, a normal or slightly reduced white blood cell count, and a normocellular bone marrow with erythroid hypoplasia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26954?source=see_link\">",
"     \"Anemia in children due to decreased red blood cell production\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately 20 to 30 percent of children with DBA recover spontaneously. Currently, patients diagnosed with DBA are treated with steroids with a 60 to 70 percent response rate. Other therapies that have been explored include androgens, antithymocyte globulin, vitamin therapy, splenectomy, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    , but they have been uniformly disappointing. Nonresponders usually are dependent on red blood cell transfusions, resulting in transfusional hemosiderosis and requiring chelation therapy to prevent damage to vital organs such as the heart and liver. Prior to the availability of hematopoietic cell transplantation (HCT), these patients had a high mortality rate due to iron overload and overwhelming infections [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/1\">",
"     1",
"    </a>",
"    ]&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26954?source=see_link&amp;anchor=H2#H2\">",
"     \"Anemia in children due to decreased red blood cell production\", section on 'Congenital pure red cell aplasia'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Because HCT has been used to treat aplastic anemia of other etiologies with success, this approach to treat patients with advanced, unresponsive DBA appeared reasonable. Several reports in the literature from different transplant centers describe successful HCT in patients with DBA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The International Bone Marrow Transplant Registry (IBMTR) is a working group of more than 400 transplant centers that cooperate in collecting data on HCT. This group has published the largest series of patients with DBA who underwent HCT [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/3\">",
"     3",
"    </a>",
"    ]. This review included 61 patients with a median age at transplant of 7 years (range 1 to 32 years). Forty-one of the patients received transplants from an HLA-identical sibling donor, 8 from a nonsibling family donor, and 12 from an unrelated donor. The median time for transplantation after diagnosis of DBA was 62 months (range 5 to 286 months). Results included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Of the 59 evaluable patients, 54 achieved neutrophil recovery with a white blood cell count of &gt;500 per mm3, (median time: 17 days, range:10 to 119 days) and 51 achieved platelet recovery, defined as a platelet count &gt;20,000 per mm3 (median time: 23 days, range 9 to 119 days). The donor source did not alter the probability of neutrophil recovery. The speed of recovery was greatest in those patients who received the lowest number of transfusions prior to transplantation.",
"     </li>",
"     <li>",
"      The cumulative incidence of graft versus host disease (GVHD) was 28 percent. There was no difference in the incidence of acute GVHD by donor source; however, chronic GVHD was lower in recipients of HCT from HLA-identical siblings.",
"     </li>",
"     <li>",
"      Overall, actuarial one-year and three-year survival were 67 and 63 percent, respectively. Transplantation from an identical HLA sibling donor compared to an alternative donor was associated with improved survival at one year (78 versus 45 percent, respectively) and three years (76 versus 39 percent).",
"     </li>",
"     <li>",
"      Of the 23 deaths after transplantation, 11 died within the first 100 days. The main causes of death included infection (n=7), graft failure (n=6), and interstitial pneumonitis (n=3).",
"     </li>",
"     <li>",
"      Of the 38 surviving patients with a median follow-up of 11 years (range: 1 to 14 years), 37 have a normal white cell count and 25 are known to be independent of red blood cell transfusion. Transfusion data are not available on the remaining 13 patients. Most of these patients had returned to a normal level of activity with minimal impairment as demonstrated by Karnofsky performance scores of 90 to 100 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Diamond Blackfan Anemia Registry of North America is a voluntary database of patients with DBA from the United States and Canada. In a report from 2006, HCT had been performed in 36 patients (median age 7 years 19 months) primarily because of transfusion dependence [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/5\">",
"     5",
"    </a>",
"    ]. Five years after HCT, the survival rate for patients receiving HCT from an HLA-matched sibling donor was 73 percent, as compared to 19 percent in patients receiving HCT from an alternative donor (umbilical cord blood, bone marrow, or peripheral blood stem cells from a matched unrelated donor, or mismatched bone marrow from a relative). Among the 16 patients who died, causes of death included infection, graft versus host disease,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    veno-occlusive disease of the liver. Graft failure was the cause of death in only one patient, who underwent HCT from an unrelated donor.",
"   </p>",
"   <p>",
"    These two retrospective studies suggest that HLA-identical sibling donor HCT is effective in the treatment of DBA that is unresponsive to immunosuppressive therapy. However, it is unclear whether alternate donor HCT is a reasonable option in the treatment of DBA unresponsive to immunosuppressive therapy. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Alternative donors'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In the literature of DBA five cases with successful umbilical cord blood transplantation have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]; four donors were siblings and one was unrelated, demonstrating the feasibility of using cord blood as a stem cell source for patients with DBA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38682?source=see_link&amp;anchor=H63572418#H63572418\">",
"     \"Sources of hematopoietic stem cells\", section on 'Umbilical cord blood'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The optimum time for HCT in DBA most likely is after a patient becomes refractory to corticosteroids and other therapy but before excessive red cell transfusion has occurred. The rarity of DBA precludes large-scale randomized trials, and progress is most likely to be made by pooling results from different transplant centers through international registries and cooperative groups, such as the registries cited above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MYELODYSPLASTIC SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The myelodysplastic syndromes (MDS) encompass a spectrum of clonal hematological disorders, characterized by abnormal proliferation and differentiation of hematopoietic precursor cells, along with ineffective hematopoiesis. MDS may be a either a primary disorder or be secondary to therapy with alkylating agents, irradiation, or both. Most of these disorders are seen in older patients, with a median age of 62 to 65 years. The clinical findings, treatment including bone marrow transplantation for MDS in adults are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link\">",
"     \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/39/8826?source=see_link\">",
"     \"Hematopoietic cell transplantation in myelodysplastic syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/26/19880?source=see_link\">",
"     \"Overview of the treatment of myelodysplastic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Childhood MDS, which is relatively uncommon, accounts for approximately 3 percent of hematologic malignancies in children and 17 percent of those developing AML [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/11\">",
"     11",
"    </a>",
"    ]. It is a more heterogeneous disorder than is adult MDS and some cases do not fit the French-American-British (FAB) criteria utilized in adults (",
"    <a class=\"graphic graphic_table graphicRef51895 \" href=\"UTD.htm?20/33/21020\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/12\">",
"     12",
"    </a>",
"    ]. In addition, many children show overlapping features of both MDS and other myeloproliferative disorders (eg, juvenile myelomonocytic leukemia [JMML, also called juvenile CML] and the monosomy 7 syndrome). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The classification of pediatric MDS is further complicated because some children develop MDS in the context of an inherited predisposition, such as neurofibromatosis type 1 (NF1), Down syndrome, and Fanconi anemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26842?source=see_link&amp;anchor=H4#H4\">",
"     \"Inherited aplastic anemia in children\", section on 'Fanconi anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MDS in children often is characterized by an aggressive clinical course; response to chemotherapeutic agents is limited, and most remissions are of short duration resulting in a high mortality rate [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Accordingly, HCT has been proposed as the treatment of choice for children with MDS, primarily due to studies in adults with MDS that show a better outcome with allogeneic HCT in younger patients. In adults, new therapeutic agents appear to have some promise and are in clinical testing. However, these agents have not been studied in children with MDS.",
"   </p>",
"   <p>",
"    Most transplant centers prefer to proceed to transplant immediately after diagnosis in children with MDS, as the outcome is extremely poor once evolution into AML has occurred. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/39/8826?source=see_link\">",
"     \"Hematopoietic cell transplantation in myelodysplastic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several reports that described successful HCT in children with MDS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]. The two largest are described below:",
"   </p>",
"   <p>",
"    A 2004 report from a single center in Seattle included 94 consecutive children (median age: 5.4 years, range: 0.7 to 17.8 years) who underwent HCT between 1976 and 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/20\">",
"     20",
"    </a>",
"    ]. No etiology was identified in 73 patients, 12 had a history of severe aplastic anemia, and one with Fanconi's anemia. Donor sources were 30 HLA matched related sibs, 27 mismatched related donors, and 37 unrelated donors. Results were as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Engraftment was achieved in almost all patients (98 percent), defined by recovery of the neutrophil count to a level &gt;500 per mm3 (median time: 21 days, range: 11 to 33 days). Platelet recovery (&gt;20,000 cells per mm3) was achieved in 72 percent of patients (median time 21 days, range: 11 to 119 days).",
"     </li>",
"     <li>",
"      GVHD occurred in 78 patients (85 percent). The risk of developing more severe GVHD was higher in patients who received HCT from unrelated or mismatched related donors.",
"     </li>",
"     <li>",
"      The cumulative incidence of relapse at five years was 30 percent.",
"     </li>",
"     <li>",
"      Overall, actuarial three year survival was 50 percent. Patients transplanted from a matched related donor had an improved survival rate of approximately 70 percent. The primary causes of death included relapse (n=18), infection (n=15), acute and chronic GVHD (n=8), and regimen-related toxicity (n=7).",
"     </li>",
"     <li>",
"      Of the 43 surviving patients with a median follow-up of 10 years (range: 1 to 25 years), most had Karnofsky performance scores of 90 to 100 percent suggesting a return to a normal level of activity with minimal impairment (",
"      <a class=\"graphic graphic_table graphicRef58785 \" href=\"UTD.htm?2/11/2236\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A 2011 report from the European Working Group of MDS in Childhood (EWOG-MDS 98 Study) included 97 patients with MDS (RAEB, RAEB-T, MDS-related AML, (",
"    <a class=\"graphic graphic_table graphicRef51895 \" href=\"UTD.htm?20/33/21020\">",
"     table 1",
"    </a>",
"    )) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/21\">",
"     21",
"    </a>",
"    ]. Median age was 11.1 years (range: 1.4 to 19 years). Donors were matched siblings in 39 cases and unrelated donors in 57. At a median follow-up of 3.9 years, five-year probabilities of overall survival, transplantation-related mortality (TRM) and relapse were 63, 21, and 21 percent, respectively. Age at transplant &gt;12 years, an interval between diagnosis and transplant &gt;4 months, and the occurrence of acute or extensive chronic GVHD were all associated with increased TRM.",
"   </p>",
"   <p>",
"    Other studies report similar results of 50 percent survival rate at a median followup that ranges from 19 months to 5 years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. In one small study of six patients younger than the age of two years undergoing HCT for MDS, all survived transplantation and were alive more than 1.5 years later [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/19\">",
"     19",
"    </a>",
"    ]. This suggests an earlier age for HCT prior to complications from MDS may improve the outcome of HCT.",
"   </p>",
"   <p>",
"    Secondary MDS, which is an extremely serious complication of cytotoxic chemotherapy, usually is fatal after standard treatment. A report from a single institution described outcomes in pediatric patients with therapy-related secondary MDS or AML, which showed a two-year disease-free survival of 24 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17030/abstract/22\">",
"     22",
"    </a>",
"    ]. These results are similar to those in adult patients undergoing HCT for treatment- related MDS. Although allogeneic HCT can be curative in this setting, regimen-related toxicity was frequent and recurrent malignancy was a major obstacle. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/39/8826?source=see_link\">",
"     \"Hematopoietic cell transplantation in myelodysplastic syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     FUTURE PROSPECTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Alternative donors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of alternative donors (eg, umbilical cord blood, mismatched related donors, matched unrelated donors) is still being evaluated in patients with beta thalassemia major, and its role in the treatment of MDS and Diamond-Blackfan anemia has yet to be defined. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5529?source=see_link&amp;anchor=H801617#H801617\">",
"     \"Efficacy of hematopoietic cell transplantation in beta thalassemia major\", section on 'Alternative donors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38682?source=see_link&amp;anchor=H63572418#H63572418\">",
"     \"Sources of hematopoietic stem cells\", section on 'Umbilical cord blood'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diamond-Blackfan anemia (DBA) and myelodysplastic syndromes are rare disorders in children that result in significant morbidity and mortality if refractory to immunosuppressive therapy. In patients with refractory disease, hematopoietic cell transplantation is an effective curative treatment, especially if the donor is an HLA-identical sibling.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Alter BP. Inherited Bone Marrow Failure Syndromes. In: Nathan and Oski's Hematology of Infancy and Childhood, Nathan DG, Orkin SH, Ginsburg D, Look AT (Eds), W.B. Saunders, Philadelphia 2003. p.280.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/2\">",
"      August CS, King E, Githens JH, et al. Establishment of erythropoiesis following bone marrow transplantation in a patient with congenital hypoplastic anemia (Diamond-Blackfan syndrome). Blood 1976; 48:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/3\">",
"      Roy V, P&eacute;rez WS, Eapen M, et al. Bone marrow transplantation for diamond-blackfan anemia. Biol Blood Marrow Transplant 2005; 11:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/4\">",
"      Mugishima H, Ohga S, Ohara A, et al. Hematopoietic stem cell transplantation for Diamond-Blackfan anemia: a report from the Aplastic Anemia Committee of the Japanese Society of Pediatric Hematology. Pediatr Transplant 2007; 11:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/5\">",
"      Lipton JM, Atsidaftos E, Zyskind I, Vlachos A. Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry. Pediatr Blood Cancer 2006; 46:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/6\">",
"      Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/7\">",
"      Vettenranta K, Saarinen UM. Cord blood stem cell transplantation for Diamond-Blackfan anemia. Bone Marrow Transplant 1997; 19:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/8\">",
"      Bonno M, Azuma E, Nakano T, et al. Successful hematopoietic reconstitution by transplantation of umbilical cord blood cells in a transfusion-dependent child with Diamond-Blackfan anemia. Bone Marrow Transplant 1997; 19:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/9\">",
"      Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/10\">",
"      Bizzetto R, Bonfim C, Rocha V, et al. Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia. Haematologica 2011; 96:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/11\">",
"      Blank J, Lange B. Preleukemia in children. J Pediatr 1981; 98:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/12\">",
"      Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/13\">",
"      Luna-Fineman S, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood 1999; 93:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/14\">",
"      Passmore SJ, Hann IM, Stiller CA, et al. Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood 1995; 85:1742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/15\">",
"      Bader-Meunier B, Mi&eacute;lot F, Tchernia G, et al. Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. French Society of Paediatric Haematology and Immunology. Br J Haematol 1996; 92:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/16\">",
"      Guinan EC, Tarbell NJ, Tantravahi R, Weinstein HJ. Bone marrow transplantation for children with myelodysplastic syndromes. Blood 1989; 73:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/17\">",
"      Rubie H, Attal M, Demur C, et al. Intensified conditioning regimen with busulfan followed by allogeneic BMT in children with myelodysplastic syndromes. Bone Marrow Transplant 1994; 13:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/18\">",
"      Locatelli F, Niemeyer C, Angelucci E, et al. Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 1997; 15:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/19\">",
"      Woolfrey AE, Gooley TA, Sievers EL, et al. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome. Blood 1998; 92:3546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/20\">",
"      Yusuf U, Frangoul HA, Gooley TA, et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant 2004; 33:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/21\">",
"      Strahm B, N&ouml;llke P, Zecca M, et al. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia 2011; 25:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17030/abstract/22\">",
"      Leahey AM, Friedman DL, Bunin NJ. Bone marrow transplantation in pediatric patients with therapy-related myelodysplasia and leukemia. Bone Marrow Transplant 1999; 23:21.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3533 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-192C8F5B95-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17030=[""].join("\n");
var outline_f16_40_17030=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAMOND-BLACKFAN ANEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MYELODYSPLASTIC SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      FUTURE PROSPECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Alternative donors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/3533\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/3533|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/33/21020\" title=\"table 1\">",
"      FAB classification of MDS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/11/2236\" title=\"table 2\">",
"      Karnofsky performance status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26954?source=related_link\">",
"      Anemia in children due to decreased red blood cell production",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/57/41882?source=related_link\">",
"      Clinical manifestations and diagnosis of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5529?source=related_link\">",
"      Efficacy of hematopoietic cell transplantation in beta thalassemia major",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/18/11562?source=related_link\">",
"      Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/50/18217?source=related_link\">",
"      Hematopoietic cell transplantation in aplastic anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/39/8826?source=related_link\">",
"      Hematopoietic cell transplantation in myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30775?source=related_link\">",
"      Hematopoietic cell transplantation in sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26842?source=related_link\">",
"      Inherited aplastic anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/26/19880?source=related_link\">",
"      Overview of the treatment of myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/49/38682?source=related_link\">",
"      Sources of hematopoietic stem cells",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_40_17031="Laser and light therapy of lower extremity telangiectasias, reticular veins and small varicose veins";
var content_f16_40_17031=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Laser and light therapy of lower extremity telangiectasias, reticular veins and small varicose veins",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17031/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17031/contributors\">",
"     Deborah L Greenberg, MD, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17031/contributors\">",
"     Sherry Scovell, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17031/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17031/contributors\">",
"     John F Eidt, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17031/contributors\">",
"     Joseph L Mills, Sr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17031/contributors\">",
"     Jeffrey S Dover, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17031/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17031/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/40/17031/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Telangiectasias and reticular veins are common venous abnormalities and are often a source of significant distress to the patient whether or not symptoms are present. The treatment of telangiectasias and reticular veins with lasers or light therapy is reviewed here. Other modalities used to treat these entities are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34521?source=see_link\">",
"     \"Overview and management of lower extremity chronic venous disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13514?source=see_link\">",
"     \"Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Telangiectasias, reticular veins and varicose veins are the visible signs of chronic venous disease, and can occur in the presence or absence of either symptoms or an underlying functional venous disorder (reflux) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/1\">",
"     1",
"    </a>",
"    ]. Sclerotherapy is the treatment of choice for the majority of superficial leg veins. When sclerotherapy is administered sequentially from deep to superficial and from larger to smaller veins, over 90 percent of vessels can be successfully treated [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/2\">",
"     2",
"    </a>",
"    ]. Candidates for laser and light therapy are those who do not tolerate or fail sclerotherapy or who have small superficial vessels that are too small to cannulate with a sclerotherapy needle [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13514?source=see_link\">",
"     \"Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Asymptomatic patients with telangiectasias or reticular veins often find the cosmetic appearance of their veins distressing. In the absence of signs of venous reflux, laser and light therapy can be performed after physical examination. The clinical evaluation of the patient with chronic venous disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13592?source=see_link\">",
"     \"Clinical evaluation of lower extremity chronic venous disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because vein recurrence rates are increased in the presence of superficial venous reflux, reflux is managed prior to treatment. Treatment with laser and light therapy is most effective for small vessels (1 to 2 mm in diameter) although vessels up to 5 mm in diameter can be treated. Larger veins do not respond as well [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34521?source=see_link&amp;anchor=H8#H8\">",
"     \"Overview and management of lower extremity chronic venous disease\", section on 'Diagnostic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laser and light therapy should not be performed in patients who have signs of acute",
"    <span class=\"nowrap\">",
"     thrombosis/phlebitis,",
"    </span>",
"    due to the increased risk of deep venous thrombosis. Pregnant patients should defer until after delivery.",
"   </p>",
"   <p>",
"    Diabetes and peripheral arterial occlusive disease (ankle-brachial index &lt;0.9) are also contraindications because these conditions are associated with an increased risk of nonhealing wounds.",
"   </p>",
"   <p>",
"    In addition, laser and light therapy may cause hyperpigmentation, which is usually temporary but can last up to a year, and hypopigmentation, which may be permanent. Both these side effects are most common in patients with tan skin and in Fitzpatrick skin types III, IV, V, and VI. A test spot is undertaken prior to treatment (",
"    <a class=\"graphic graphic_table graphicRef60541 \" href=\"UTD.htm?15/37/15963\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Pigmentation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATIENT COUNSELING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to offer laser or light therapy depends upon symptoms, extent of lower extremity disease, patient expectations, and likelihood of providing a durable benefit either with respect to appearance or improvement in symptoms.",
"   </p>",
"   <p>",
"    Patients should be counseled carefully prior to treatment. The patient is informed that veins will lighten and become less noticeable, but may not completely disappear. Multiple treatments are typically required to achieve the desired effect, and alteration in skin pigmentation can occur.",
"   </p>",
"   <p>",
"    For all patients, it is important to address patient expectations, potential complications and to document veins photographically prior to each treatment. These photographs should be reviewed with the patient periodically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     LASER/LIGHT PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lasers emit a single, coherent wavelength of light, while intense pulsed light (IPL) sources emit white light from 515 nm to 1200 nm that is usually filtered to certain broad wavelengths (",
"    <a class=\"graphic graphic_figure graphicRef69001 \" href=\"UTD.htm?5/29/5585\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Laser therapy of venous structures is based on the concept of selective photothermolysis (ie, selective thermal confinement of light-induced damage) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. Pulsed lasers and light sources heat the target tissue, inducing thermal injury with limited damage to the surrounding structures. The wavelength of light is chosen based upon the chromophore (the part of a molecule responsible for its color) of the target structure and the depth of the vessel. The oxyhemoglobin contained within red blood cells has three major absorption peaks at 418, 542, and 577 nm, with an additional infrared absorption around 1000 nm (",
"    <a class=\"graphic graphic_figure graphicRef63932 \" href=\"UTD.htm?28/5/28766\">",
"     figure 2",
"    </a>",
"    ). Green, yellow and infrared laser and light sources are effectively absorbed by leg veins.",
"   </p>",
"   <p>",
"    The selected duration of the light pulse determines the size of the vessel that will respond to treatment. Shorter pulses selectively heat smaller vessels (&lt;2 mm) and longer pulse duration light sources are effective for slightly larger vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other parameters, such as fluence (energy density), spot size, and cooling are also important factors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/25/32151?source=see_link&amp;anchor=H13#H13\">",
"     \"Basic principles of medical lasers\", section on 'Tissue ablation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     LASER AND LIGHT SOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;No single laser type is used to treat the variety of vascular abnormalities seen in clinical practice. The specific laser selected for an individual patient depends upon the size and depth of the vessels to be treated (",
"    <a class=\"graphic graphic_table graphicRef80164 \" href=\"UTD.htm?19/47/20220\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/1\">",
"     1",
"    </a>",
"    ]. Patient skin phototype is also important (",
"    <a class=\"graphic graphic_table graphicRef60541 \" href=\"UTD.htm?15/37/15963\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pulse dye laser",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulse dye lasers (PDLs) emit light at 585 and 595 nm at pulse durations of 0.45 to 40 msecs. The yellow wavelength matches the third oxyhemoglobin peak (",
"    <a class=\"graphic graphic_figure graphicRef77528 \" href=\"UTD.htm?40/57/41873\">",
"     figure 3",
"    </a>",
"    ). PDLs are most effective for treating small lower extremity veins less than 1.5 mm in diameter in light skin type patients (",
"    <a class=\"graphic graphic_table graphicRef80164 \" href=\"UTD.htm?19/47/20220\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Potassium titanyl phosphate laser",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potassium titanyl phosphate (KTP) lasers emit light at 532 nm at pulse durations in the millisecond range (",
"    <a class=\"graphic graphic_figure graphicRef77528 \" href=\"UTD.htm?40/57/41873\">",
"     figure 3",
"    </a>",
"    ). The green wavelength matches the second oxyhemoglobin peak overlapping the absorption peak of melanin. Veins with diameters ranging from 0.5 to 1.5 mm can be effectively treated in light skin type patients (",
"    <a class=\"graphic graphic_table graphicRef80164 \" href=\"UTD.htm?19/47/20220\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diode laser",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diode lasers emit light at a single wavelength between 800 and 900 nm, penetrating more deeply and with less absorption by melanin than PDL and KTP lasers [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/13\">",
"     13",
"    </a>",
"    ]. Veins up to 4 mm in diameter can be treated using this laser (",
"    <a class=\"graphic graphic_figure graphicRef77528 \" href=\"UTD.htm?40/57/41873\">",
"     figure 3",
"    </a>",
"    ). Diode lasers with a 900 nm wavelength have been used in conjunction with radiofrequency current [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/14\">",
"     14",
"    </a>",
"    ]. The combination is an effective treatment for lower extremity veins. The diode laser can also be augmented with intravenous injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/44/32450?source=see_link\">",
"     indocyanine green",
"    </a>",
"    , which enhances light absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/15\">",
"     15",
"    </a>",
"    ]. The diode laser should be limited to skin types I to IV (",
"    <a class=\"graphic graphic_table graphicRef80164 \" href=\"UTD.htm?19/47/20220\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Nd:YAG laser",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neodymium-doped: yttrium aluminum garnet (Nd:YAG) lasers emit light at a wavelength of 1064 nm, at pulse durations in the millisecond range (",
"    <a class=\"graphic graphic_figure graphicRef77528 \" href=\"UTD.htm?40/57/41873\">",
"     figure 3",
"    </a>",
"    ). This longer wavelength penetrates to deeper levels and, with long pulse durations, can be used to treat veins from 0.3 mm to 3 mm in diameter. Because of lower absorption in pigment, Nd:YAG lasers are less likely to cause pigmentary changes and are safer to use in darker skin types (",
"    <a class=\"graphic graphic_table graphicRef80164 \" href=\"UTD.htm?19/47/20220\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/12,16\">",
"     12,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Alexandrite laser",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alexandrite lasers emit light at a wavelength of 755 nm with a pulse duration in the millisecond range (",
"    <a class=\"graphic graphic_figure graphicRef77528 \" href=\"UTD.htm?40/57/41873\">",
"     figure 3",
"    </a>",
"    ). The wavelength corresponds to absorption by deoxygenated hemoglobin, but also to absorption by melanin. Lower extremity veins may respond, but this laser should be limited to nontanned skin types I, II, and III (",
"    <a class=\"graphic graphic_table graphicRef80164 \" href=\"UTD.htm?19/47/20220\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Intense pulsed light sources",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intense pulsed light (IPL) sources emit white light from 515 nm to 1200 nm, but it is usually filtered to certain broad wavelengths. IPL sources are most effective for superficial, red telangiectasias &lt;1 mm in diameter in fair-skin individuals (",
"    <a class=\"graphic graphic_table graphicRef80164 \" href=\"UTD.htm?19/47/20220\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the laser or light source and area to be treated have been selected, the patient is placed in a comfortable position, and protective eyewear is given to the patient and all personnel in the room. The use of eye protection is essential, and when operating class 4 lasers (includes most medical lasers), it is required in the workplace by the United States Occupational Safety and Health Administration (OSHA) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Detailed treatment parameters for each of the devices listed above are beyond the scope of this topic but can be found in specialty reviews [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/4\">",
"     4",
"    </a>",
"    ]. The parameters for treatment are entered into the",
"    <span class=\"nowrap\">",
"     laser/light",
"    </span>",
"    control panel and treatment proceeds by first cooling the skin over the vessels and then activating the",
"    <span class=\"nowrap\">",
"     laser/light",
"    </span>",
"    over the target vessel(s). The patient will feel anything from a very mild sting to a strong pinching and burning sensation when the laser is activated. The application of a topical anesthetic agent can be used to lessen pain. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Adverse reactions'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A visible clearing of the vein should be seen, but if not, the vessel can be treated again or the laser parameters adjusted to improve the effect. To avoid burns, no more than three attempts should be tried over the same area of skin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;No dressings are needed. Application of compression bandages is suggested by some, but not all, practitioners. The patient may return to their normal daily activities immediately, including work. There is no evidence that avoiding exercise leads to better results. Patients should avoid sun exposure to the treated areas. Alternatively, sunscreen with a high sun protection factor (SPF 30) may be applied to the treated areas.",
"   </p>",
"   <p>",
"    Vessels may need more than one treatment to achieve optimum results, and repeat therapy is generally performed within four to six weeks. There is some evidence, at least with long pulsed Nd:YAG lasers, that waiting eight weeks between treatments yields more improvement per treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ADVERSE REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common local reactions associated with laser therapy include: pain, redness, swelling, bruising, and itching. These are transient and usually resolve quickly. More significant adverse reactions include: telangiectatic matting, pigmentation changes, hyperpigmentation, hypopigmentation, ulceration, thrombophlebitis, and scarring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment is usually well tolerated. Pain is short lived and usually lasts only seconds to minutes after treatment. The application of a topical anesthetic (eg, EMLA&reg; cream, EleMax&reg;, 30% xylocaine gel, 7%",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    , 7%",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/12/36032?source=see_link\">",
"     tetracaine",
"    </a>",
"    ) for 30 to 60 minutes prior to the procedure can lessen the degree of pain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bruising",
"    </span>",
"    &nbsp;&mdash;&nbsp;Purpura and ecchymosis are due to vessel wall rupture resulting in leakage of blood into the surrounding tissue. These reactions are most likely to occur with short pulsed laser treatments (eg PDL), and usually occur within minutes of treatment. Post-treatment bruising is a significant drawback for the alexandrite and long PDL lasers (",
"    <a class=\"graphic graphic_table graphicRef80164 \" href=\"UTD.htm?19/47/20220\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/9,12\">",
"     9,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Pigmentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperpigmentation and hypopigmentation are common in patients with skin type III, IV, V, or VI, and usually develop within three weeks after treatment. Hyperpigmentation, which is due to hemosiderin deposition, is usually temporary but may last up to a year or can be permanent. Hypopigmentation may also be permanent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Telangiectatic matting",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with sclerotherapy, telangiectatic matting consists of multiple, fine dilated vessels in the area of laser treatment (",
"    <a class=\"graphic graphic_picture graphicRef74776 \" href=\"UTD.htm?13/16/13568\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Thrombophlebitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thrombosis has been reported in the superficial veins following laser therapy. It may take up to six weeks to resolve, but rarely has sequelae. Deep vein thrombosis is exceedingly rare and is more likely related to factors not directly associated with the technique. Superficial thrombophlebitis is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/25/43417?source=see_link\">",
"     \"Superficial thrombophlebitis of the lower extremity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few trials are available comparing different types of lasers and light sources to each other for the treatment of lower extremity venous disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/12,14\">",
"     12,14",
"    </a>",
"    ]. In observational studies, the long-pulsed Nd:YAG laser appears to be the best device as a single laser modality in the treatment of lower extremity telangiectasias, reticular veins, and small varicose veins [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. Use of the Nd:YAG laser results in clearance of more than 75 percent of veins in the majority of sites and results are maintained for at least 12 months following treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/12,16,21\">",
"     12,16,21",
"    </a>",
"    ]. However, in one study, histologic specimens three months post-therapy showed recanalization, suggesting there may be a risk for vein recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/22\">",
"     22",
"    </a>",
"    ]. Optimal laser settings continue to be evaluated. Combinations of lasers have also been used [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The value of the Nd:YAG laser was illustrated in a prospective study of 22 patients that evaluated vessel clearance rates of the Nd:YAG compared with either the alexandrite or diode laser in the treatment of vessels ranging from 0.3 mm to 3 mm [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/12\">",
"     12",
"    </a>",
"    ]. Thirty-six sets of comparable sites were treated. Greater than 75 percent improvement at three months of follow-up was observed at 88 percent of the Nd:YAG sites, compared with 29 percent of the diode sites and 33 percent of the alexandrite sites.",
"   </p>",
"   <p>",
"    Variable clearance rates are observed with other laser modalities and depend upon the size and depth of the vessels treated. Most studies are small and the best results are seen in groups of patients with uniform vessel size selected specifically for the strength of a given laser type. Clearance of &gt;75 percent of vessels treated ranges from 10 percent of patients using the diode laser (800 nm) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/24\">",
"     24",
"    </a>",
"    ], to 93 percent of patients with the KTP laser [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Laser versus sclerotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In spite of improved laser technology, sclerotherapy remains the treatment of choice for lower extremity telangiectasias, reticular veins, and small varicose veins. Sclerotherapy clearly works better on larger veins, such as the reticular veins and larger spider veins, while",
"    <span class=\"nowrap\">",
"     laser/light",
"    </span>",
"    therapy is more beneficial for smaller telangiectasias. As such, they are complimentary procedures.",
"   </p>",
"   <p>",
"    Three small non-randomized studies compared laser with sclerotherapy for the treatment of telangiectasias. One study concluded that laser therapy was less efficacious and more expensive than sclerotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/3\">",
"     3",
"    </a>",
"    ]. The second demonstrated no differences in the clearance of veins by objective measures; however, patients still favored sclerotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/26\">",
"     26",
"    </a>",
"    ]. The third study evaluated combined laser and sclerotherapy approaches and determined that clearance of veins was improved with sclerotherapy followed by laser compared with laser followed by sclerotherapy, laser alone, or sclerotherapy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17031/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     COST",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laser therapy of telangiectasias, reticular veins, and small varicose veins is generally considered a cosmetic treatment and is not typically covered by insurance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dilated veins can occur in the presence or absence of either symptoms or an underlying functional venous disorder. Telangiectasias, reticular veins, and small varicose veins can cause symptoms, and are often a source of significant distress to the patient even in the absence of symptoms. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The presence of lower extremity telangiectasias, reticular veins, or small varicose veins in the lower extremities may indicate an underlying functional venous disorder, especially when associated with symptoms (aching, swelling, heaviness). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34521?source=see_link\">",
"       \"Overview and management of lower extremity chronic venous disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Symptomatic patients with lower extremity telangiectasias, reticular veins, or small varicose veins should undergo further evaluation with venous duplex to identify the presence of superficial or deep venous insufficiency, which alters treatment options. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34521?source=see_link&amp;anchor=H8#H8\">",
"       \"Overview and management of lower extremity chronic venous disease\", section on 'Diagnostic evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Laser therapy is the only option for treatment of telangiectasias too small to access with a needle, patients allergic to sclerosing agents or afraid of needles, or those who have failed sclerotherapy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest laser therapy over sclerotherapy for treatment of telangiectatic matting resulting from either prior sclerotherapy or saphenous ablation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Laser versus sclerotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We avoid laser therapy of lower extremity telangiectasias, reticular veins, or small varicose veins in patients with Fitzpatrick skin types III, IV, V, and VI due to the risk of hypopigmentation. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Adverse reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common local adverse reactions to laser treatment include pain, bruising, altered skin pigmentation, and telangiectatic matting. The incidence of these reactions depends upon the",
"      <span class=\"nowrap\">",
"       laser/light",
"      </span>",
"      modality chosen and patient skin type. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Adverse reactions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest the use of the Nd:YAG laser over other laser types for the treatment of most lower extremity telangiectasias, reticular veins and small varicose veins (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Nd:YAG laser is effective for treatment over a wider range of vein diameters and depths with fewer adverse reactions. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/1\">",
"      Chiesa R, Marone EM, Limoni C, et al. Chronic venous disorders: correlation between visible signs, symptoms, and presence of functional disease. J Vasc Surg 2007; 46:322.",
"     </a>",
"    </li>",
"    <li>",
"     Procedures in Cosmetic Dermatology Series: Treatment of leg veins, Alam, M, Nguyen (Eds), Elsevier Saunders, Philadelphia 2006..",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/3\">",
"      Lupton JR, Alster TS, Romero P. Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases. Dermatol Surg 2002; 28:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/4\">",
"      McCoppin HH, Hovenic WW, Wheeland RG. Laser treatment of superficial leg veins: a review. Dermatol Surg 2011; 37:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/5\">",
"      Dover JS, Sadick NS, Goldman MP. The role of lasers and light sources in the treatment of leg veins. Dermatol Surg 1999; 25:328.",
"     </a>",
"    </li>",
"    <li>",
"     Hsu, J. Leg vein management. In: Atlas of Cosmetic Dermatology, 2, Kaminer, MS, Dover, JS, Arndt, KA (Eds), Harcourt Saunders, Philadelphia 2009. p.455.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/7\">",
"      Weiss RA, Dover JS. Laser surgery of leg veins. Dermatol Clin 2002; 20:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/8\">",
"      Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983; 220:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/9\">",
"      Kunishige JH, Goldberg LH, Friedman PM. Laser therapy for leg veins. Clin Dermatol 2007; 25:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/10\">",
"      Wollina U, Schmidt WD, Hercogova J, Fassler D. Laser therapy of spider leg veins. J Cosmet Dermatol 2003; 2:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/11\">",
"      Alora MB, Stern RS, Arndt KA, Dover JS. Comparison of the 595 nm long-pulse (1.5 msec) and ultralong-pulse (4 msec) lasers in the treatment of leg veins. Dermatol Surg 1999; 25:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/12\">",
"      Eremia S, Li C, Umar SH. A side-by-side comparative study of 1064 nm Nd:YAG, 810 nm diode and 755 nm alexandrite lasers for treatment of 0.3-3 mm leg veins. Dermatol Surg 2002; 28:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/13\">",
"      Levy JL, Berwald C. Treatment of vascular abnormalities with a long-pulse diode at 980 nm. J Cosmet Laser Ther 2004; 6:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/14\">",
"      Trelles MA, Mart&iacute;n-V&aacute;zquez M, Trelles OR, Mordon SR. Treatment effects of combined radio-frequency current and a 900 nm diode laser on leg blood vessels. Lasers Surg Med 2006; 38:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/15\">",
"      Klein A, B&auml;umler W, Koller M, et al. Indocyanine green-augmented diode laser therapy of telangiectatic leg veins: a randomized controlled proof-of-concept trial. Lasers Surg Med 2012; 44:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/16\">",
"      Omura NE, Dover JS, Arndt KA, Kauvar AN. Treatment of reticular leg veins with a 1064 nm long-pulsed Nd:YAG laser. J Am Acad Dermatol 2003; 48:76.",
"     </a>",
"    </li>",
"    <li>",
"     Occupational Safety and Health Administration. www.osha.gov (Accessed on March 31, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/18\">",
"      Chen JZ, Alexiades-Armenakas MR, Bernstein LJ, et al. Two randomized, double-blind, placebo-controlled studies evaluating the S-Caine Peel for induction of local anesthesia before long-pulsed Nd:YAG laser therapy for leg veins. Dermatol Surg 2003; 29:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/19\">",
"      Sadick NS. Long-term results with a multiple synchronized-pulse 1064 nm Nd:YAG laser for the treatment of leg venulectasias and reticular veins. Dermatol Surg 2001; 27:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/20\">",
"      Trelles MA, Allones I, Mart&iacute;n-V&aacute;zquez MJ, et al. Long pulse Nd:YAG laser for treatment of leg veins in 40 patients with assessments at 6 and 12 months. Lasers Surg Med 2004; 35:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/21\">",
"      Bernstein EF, Kornbluth S, Brown DB, Black J. Treatment of spider veins using a 10 millisecond pulse-duration frequency-doubled neodymium YAG laser. Dermatol Surg 1999; 25:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/22\">",
"      Sadick NS, Prieto VG, Shea CR, et al. Clinical and pathophysiologic correlates of 1064-nm Nd:Yag laser treatment of reticular veins and venulectasias. Arch Dermatol 2001; 137:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/23\">",
"      Trelles MA, Weiss R, Moreno-Moragas J, et al. Treatment of leg veins with combined pulsed dye and Nd:YAG lasers: 60 patients assessed at 6 months. Lasers Surg Med 2010; 42:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/24\">",
"      Trelles MA, Allones I, Alvarez J, et al. The 800-nm diode laser in the treatment of leg veins: assessment at 6 months. J Am Acad Dermatol 2006; 54:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/25\">",
"      Fournier N, Brisot D, Mordon S. Treatment of leg telangiectases with a 532 nm KTP laser in multipulse mode. Dermatol Surg 2002; 28:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/26\">",
"      Coles CM, Werner RS, Zelickson BD. Comparative pilot study evaluating the treatment of leg veins with a long pulse ND:YAG laser and sclerotherapy. Lasers Surg Med 2002; 30:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17031/abstract/27\">",
"      Levy JL, Elbahr C, Jouve E, Mordon S. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment. Lasers Surg Med 2004; 34:273.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8176 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.10.40.232-BF0A88A09A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17031=[""].join("\n");
var outline_f16_40_17031=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATIENT COUNSELING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      LASER/LIGHT PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      LASER AND LIGHT SOURCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pulse dye laser",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Potassium titanyl phosphate laser",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diode laser",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Nd:YAG laser",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Alexandrite laser",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Intense pulsed light sources",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ADVERSE REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bruising",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Pigmentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Telangiectatic matting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Thrombophlebitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Laser versus sclerotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      COST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/8176\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8176|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/29/5585\" title=\"figure 1\">",
"      Wavelengths of light used for venous laser therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/5/28766\" title=\"figure 2\">",
"      Hemoglobin absorption spectra",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/57/41873\" title=\"figure 3\">",
"      Absorption of laser and light by various tissues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8176|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/16/13568\" title=\"picture 1\">",
"      Telangiectatic matting following sclerotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8176|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/37/15963\" title=\"table 1\">",
"      Fitzpatrick skin phototypes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/47/20220\" title=\"table 2\">",
"      Laser and light sources for treating leg veins",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/25/32151?source=related_link\">",
"      Basic principles of medical lasers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/17/13592?source=related_link\">",
"      Clinical evaluation of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13514?source=related_link\">",
"      Liquid and foam sclerotherapy techniques for the treatment of lower extremity veins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34521?source=related_link\">",
"      Overview and management of lower extremity chronic venous disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/25/43417?source=related_link\">",
"      Superficial thrombophlebitis of the lower extremity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_40_17032="Principles of computed tomography of the chest";
var content_f16_40_17032=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Principles of computed tomography of the chest",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17032/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17032/contributors\">",
"     Paul Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17032/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17032/contributors\">",
"     Nestor L Muller, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17032/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17032/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/40/17032/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography (CT) is an imaging technique that has revolutionized medical imaging. It is widely available, fast, and provides a detailed view of the internal organs and structures.",
"   </p>",
"   <p>",
"    The two major types of CT are helical CT and conventional, incremental, step-and-shoot (ie, axial) CT. Helical CT is most common, but conventional step-and-shoot CT is used for high-resolution CT scanning of the lungs, coronary artery calcification scoring, and prospective ECG-gated coronary CT angiography.",
"   </p>",
"   <p>",
"    The technical aspects of CT are reviewed here. The role of CT in various clinical situations is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"     \"High resolution computed tomography of the lungs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/43/17080?source=see_link\">",
"     \"Computed tomographic and positron emission tomographic scanning of pulmonary nodules\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=see_link\">",
"     \"Role of imaging in the staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18950?source=see_link\">",
"     \"Computed tomography of the hepatobiliary tract\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/26/20906?source=see_link\">",
"     \"Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL DESCRIPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principal components of CT are the x-ray tube and a diametrically opposed array of detectors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The x-ray tube rotates around the patient and generates an x-ray beam (",
"      <a class=\"graphic graphic_figure graphicRef68855 \" href=\"UTD.htm?22/61/23519\">",
"       figure 1",
"      </a>",
"      ). The gantry motion is helical during helical CT and circular during conventional step-and-shoot CT.",
"     </li>",
"     <li>",
"      The detectors concurrently record the radiation that traverses the body, while rejecting scattered radiation emanating from outside the x-ray tube focal spot (the area of the target of the x-ray tube) with collimators on the x-ray tube side and on the detector side.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During conventional step-and-shoot CT, the patient is moved into the desired position (ie, step) and then the x-ray tube rotates around the patient (ie, shoot). These two steps are repeated, with the table inching sequentially along the z-axis while the x-ray production is interrupted, until the scan is complete. In contrast, during helical CT, the rotation of the x-ray tube and the movement of the patient through the gantry (the portion of the CT scanner that contains the x-ray tube and detectors) are continuous. This uninterrupted production of radiation is why the radiation exposure is much higher during helical acquisition.",
"   </p>",
"   <p>",
"    Helical CT facilitates the uninterrupted acquisition of raw data. The data are digitized by analog to digital converters and then reconstructed into axial images using array processors and interpolation algorithms [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/2\">",
"     2",
"    </a>",
"    ]. These devices record, digitize, store, and reconstruct 800 to 1500 views per 360 degrees of rotation around the patient. Each view is acquired at a slightly different angle using mathematical algorithms.",
"   </p>",
"   <p>",
"    The resulting tomographic images are composites of individual volume elements (voxels) displayed as two-dimensional units (pixels). Each pixel has a numerical value that is called a CT number:",
"   </p>",
"   <p>",
"    CT number = [(AM -",
"    <span class=\"nowrap\">",
"     AW)/AW]",
"    </span>",
"    x 1000",
"   </p>",
"   <p>",
"    where AM is the linear attenuation coefficient of a material (eg, soft tissue, bone, fat) and AW is the linear attenuation coefficient of water. The CT number is expressed in Hounsfield units (HU). The HU scale is calibrated from -1000 HU for gas to +1000 HU for high attenuation metal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Configuration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The configuration of CT scanners has changed. The stepwise approach to imaging used by conventional step-and-shoot CT was previously necessary because gantry cables needed to unwind through reverse rotation of the gantry. However, the invention of slip rings allowed electrical current to be supplied to the scanner and electronic data to be transferred from the gantry to the computer without gantry cables. It also allowed helical CT scanners to be developed, since continuous rotation of the x-ray tube became possible without gantry cables. Most imaging is now done by helical CT scanners, which are also called spiral or volumetric CT scanners (",
"    <a class=\"graphic graphic_figure graphicRef68855 \" href=\"UTD.htm?22/61/23519\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Advantages'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Many institutions are using helical CT scanners that are multidetector and multichannel. Such scanners are also called multislice helical CT scanners. Multislice helical CT scanners use a cone-shaped x-ray beam with wider collimation, which strikes many of the 16 to 320 parallel detector rows during a single scanning cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/3-7\">",
"     3-7",
"    </a>",
"    ]. Sixty-four slice helical CT scanners are in wide clinical use, while 320 slice helical CT scanners and dual source helical CT scanners have been introduced [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Multislice helical CT'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Dual source CT scanners are capable of either of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Using two x-ray sources to scan simultaneously generates two data sets at a 90 degree angle offset. This improves the temporal resolution by decreasing the smallest time interval that can resolve a dynamic process with helical CT to 83 msec [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Using dual energy simultaneously allows subtraction of unwanted calcium or other high attenuation materials, since measured attenuation of materials varies with different incident energy beams. Iodine maps after intravenous injection of contrast material allow for determination of perfusion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ADVANTAGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT is superior to conventional radiography because of its exquisite contrast resolution. CT uses point attenuation, which can detect differences in contrast of less than 0.5 percent. In comparison, conventional radiography uses ray attenuation, which can detect differences in contrast of approximately 5 percent. This represents a ten times increase in contrast resolution. Another advantage of CT over conventional radiography is that anatomic structures in different planes are not superimposed on one another.",
"   </p>",
"   <p>",
"    Helical CT has several advantages over prior generations of CT scanners. Its primary advantage is that it is faster, obtaining an image by scanning only 180 degrees (ie, half-scan imaging) with a gantry rotation time of 0.27 to 0.35 seconds [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/9-13\">",
"     9-13",
"    </a>",
"    ]. Consequences of this speed are that helical CT minimizes motion artifacts, can be used for cardiac imaging, and can improve scan coverage during a single breath hold. The helical, volumetric data set eliminates respiratory misregistration, defined as gaps or overlap in images obtained over several breaths due to variation in the depth of inspirations.",
"   </p>",
"   <p>",
"    Helical CT can reconstruct high quality, near-isotropic, overlapping axial source images that allow for multiplanar two-dimensional and three-dimensional reformatted images at arbitrary levels within the scanned volume [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/9-13\">",
"     9-13",
"    </a>",
"    ]. It can also be used for CT angiography because it can rapidly acquire data during the bolus or arterial phase of intravenous contrast injection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SETTINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several of the parameters used in helical CT are set by the operator. These include the collimation of the x-ray beam, pitch, field of view, duration of the helix, reconstruction interval, and reconstruction phase in cardiac CT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Collimation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Collimation refers to the thickness of the x-ray beam. In standard single-slice helical CT, collimation determines the thickness of the section:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Standard collimation for scanning the chest is 2.5 mm.",
"     </li>",
"     <li>",
"      Narrow collimation (1 to 1.25 mm) is used for CT pulmonary angiography, imaging the lung parenchyma, and imaging small pulmonary nodules.",
"     </li>",
"     <li>",
"      Wide collimation (2.5 mm) is used in heavy patients to decrease the quantum noise, although this also decreases the spatial resolution.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While collimation determines the thickness of the section in standard single-slice helical CT, it is the detector width that determines the thickness of the section in multislice helical CT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Pitch",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pitch is the table speed per rotation of the x-ray beam (ie, the table feed or table increment) divided by the collimation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A pitch of 1 is generally used.",
"     </li>",
"     <li>",
"      A pitch &gt;1 allows for greater coverage per unit time. The advantage of a pitch &gt;1 is that it reduces the patient's radiation exposure and shortens the acquisition time of the data set. However, it also decreases the z-axis (ie, longitudinal) resolution, which blurs the image. As an example, helical CT with a pitch of 2 increases the perceived slice thickness by 20 to 30 percent compared to conventional CT with a pitch of 1 [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/2,15,16\">",
"       2,15,16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A pitch &lt;1 increases the quality of reformatted images considerably. However, it also increases the duration of the scan and the patient's radiation exposure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Duration of the helix",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of the helix is the time that is necessary to scan an entire volume of tissue. As examples, with a 64 slice helical CT, the cardiac structures can be scanned in 5 to 8 seconds, the entire chest in 10 to 12 seconds, and the entire body in 15 to 20 seconds. A 320 slice helical CT can scan the entire heart in less than one second.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Reconstruction interval",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reconstruction interval (also called the slice index) is the distance between reconstructed axial images. It determines the degree of overlap of reformatted sections [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/2,17,18\">",
"     2,17,18",
"    </a>",
"    ]. A reconstruction interval of half the detector width is frequently used. This achieves 50 percent overlap, which increases the visibility of small lesions and eliminates partial volume effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Gantry rotation time",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gantry rotation time (ie, the cycle or revolution time) is generally not set by the operator. It refers to the duration in which the x-ray beam rotates 360 degrees. It is usually 0.27 to 0.70 seconds. The limiting factor for decreasing the rotation time is the gravitational stress on the equipment, since G-forces in excess of 15 are generated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     BREATHING INSTRUCTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breathing instructions are important when the chest is being scanned. The goal is for the patient to suspend respiration at the end of a deep inspiration to total lung capacity. This prevents motion artifact and respiratory misregistration (gaps or overlap in breathing cycles due to variation in the depth of inspiration).",
"   </p>",
"   <p>",
"    Patients should hyperventilate by taking three or four deep inspirations. Then, they should suspend respiration at the end of an inspiration for 10 to 32 seconds. This is called the single acquisition, single breathhold technique [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients who cannot hold their breath long enough to complete a scan, multiple preprogrammed helical scans of 5 to 15 seconds can be performed with breathing intervals of 6 to 7 seconds between scans. This approach is called the split breath hold or variable mode technique (",
"    <a class=\"graphic graphic_figure graphicRef64610 \" href=\"UTD.htm?33/12/33999\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/19\">",
"     19",
"    </a>",
"    ]. It is used less commonly now, since scan cycles of less than one second and multislice CT scanning have decreased the duration of the breath hold necessary for patients to complete the scan.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     INTRAVENOUS CONTRAST",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following intravenous injection, contrast material distribution occurs in three pharmacokinetic phases:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The early vascular or bolus phase corresponds to the duration of the contrast material injection. Arterial enhancement increases gradually and reaches a peak value at the completion of the injection. The rate of the increase is proportional to the rate of the injection, the iodine concentration, and the volume of contrast material. In contrast, the rate of increase is inversely proportional to the patient's cardiac output and body weight [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/17,19\">",
"       17,19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The redistribution phase occurs within one to three minutes after the injection of contrast material. During this phase, the contrast agent diffuses from the intravascular to the extravascular compartment.",
"     </li>",
"     <li>",
"      During the equilibrium phase, the contrast material in the intravascular and extravascular compartments reaches a dynamic equilibrium. This phase is not desirable for imaging.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For a helical CT of the chest, the goal is to scan the chest during the bolus phase and the liver during the redistribution phase. However, scanning the lung parenchyma can extend into the redistribution and equilibrium phases without any decrement in quality if pleural, hilar, or mediastinal pathology is not expected.",
"   </p>",
"   <p>",
"    Timing the scan with respect to the intravenous injection of contrast material requires that the injection rate, duration of the injection, volume of contrast material, recirculation time, and scan duration be considered. Low osmolar or iso-osmolar nonionic contrast agents are preferred. They are injected intravenously at a rate of 3 to 5 mL per second, with a delay of 30 to 45 seconds. Shorter delay times are used when performing CT pulmonary angiography or CT coronary arteriography. In such cases, the optimal delay is determined with a timing bolus or with bolus tracking technology. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'CT angiography'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     DATA PROCESSING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each rotation of the x-ray tube generates data for an angled plane of section. From these data, interpolation algorithms generate virtual axial displays by interpolating data points below and above the plane of section [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/2\">",
"     2",
"    </a>",
"    ]. A wide algorithm interpolates points separated by a 360 degree rotation, while a slim algorithm interpolates points separated by a 180 degree rotation (",
"    <a class=\"graphic graphic_figure graphicRef51274 \" href=\"UTD.htm?42/34/43566\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     IMAGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The x- and y-axis resolutions (also called in-plane resolution) are determined by the interpolation algorithm, section sensitivity profile, x-ray tube focal spot, and voxel matrix configuration. The z-axis resolution is determined by the interpolation algorithm, section thickness, pitch, and reconstruction interval.",
"   </p>",
"   <p>",
"    Ideally, the z-axis resolution should be the same as the x- and y-axis resolutions. This is called isotropic imaging and it is important because it allows for accurate multiplanar reformations, devoid of &ldquo;stair artifacts&rdquo;. &nbsp;It facilitates the depiction of findings in any desired plane and in three dimensions.",
"   </p>",
"   <p>",
"    In multidetector row CT scanners, the number of slices is determined by electronic channels that combine several detector rows to form one slice. Newer helical CT scanners with 64 or more channels and a detector width of 0.5 to 0.625 mm increase the z-axis resolution, so that near-isotropic resolution is achieved.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     TWO-DIMENSIONAL AND THREE-DIMENSIONAL RENDERING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Production of two-dimensional and three-dimensional images is a sophisticated application of helical CT. The images are more dramatic than routine axial images, but the process is labor intensive, requires a dedicated workstation, and includes interpolation, segmentation, and rendering [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. Interpolation involves constructing new data points within the range of known data points, segmentation is the process of partitioning a digital image into multiple segments thereby allowing structures of little interest to be eliminated or subtracted, and rendering is the generation of an image from a model utilizing the axial source images.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Two-dimensional",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maximum intensity projection (MIP), minimum intensity projection (MINIP), multiplanar reformation (MPR), and curved MPR are two-dimensional rendering techniques.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MIP is obtained by orienting algebraic rays along a preselected projection and then determining the maximum attenuation value encountered by the rays [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/22-24\">",
"       22-24",
"      </a>",
"      ]. The pixels with the highest values are preferentially displayed. The two-dimensional quality of the images produced with MIP is excellent and approaches the quality of conventional angiograms. They are diagnostically more useful than volume rendering or shaded surface display. Their disadvantage is the loss of contrast resolution ensuing from the preferential display of the maximal attenuation in the data set which is brought forward in the image and may cover up other structures in the vessel lumen.",
"     </li>",
"     <li>",
"      MINIP is similar to MIP except that it preferentially displays the pixels with the minimum attenuation values encountered by the rays. It provides an excellent image of the trachea and bronchi.",
"     </li>",
"     <li>",
"      Curved MPR uses a single voxel plane that is perpendicular to a curvilinear line to longitudinally display a tubular structure. A volume is generated by stacking the axial source images sequentially. Curved multiplanar images track the center of a tubular structure and the entire length of the tubular structure is then displayed as a single image (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74724 \" href=\"UTD.htm?35/20/36160\">",
"       image 1",
"      </a>",
"      ). The appearance of the tubular structure's lumen and wall can be excellent, although the quality of the image is dependent upon the skill of the operator or the quality of the software. The surrounding structures are frequently distorted [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/22\">",
"       22",
"      </a>",
"      ]. Newer algorithms automatically render two-dimensional images using both curved MPR and stretched planar reformatting (similar to curved MPR except that it uses a straight line instead of a curvilinear line). Curved MPR is useful for CT coronary arteriography. Centerline technology facilitates rendering and display, and relies heavily on precise placement of the center line.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Three-dimensional",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three-dimensional rendering requires precisely defining the volume that is to be imaged. The volume should be kept small, since the z-axis resolution is inversely proportional to the length of the imaging volume. Several advanced techniques are available to display the volumetric data set in three dimensions once the imaging volume has been defined:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Shaded surface display (SSD) &ndash; SSD establishes a threshold value, above and below which pixels are excluded. The remaining pixels are manipulated by the computer to produce images with an excellent vascular contour, although a loss of contrast resolution remains a problem (ie, calcified arteriosclerotic plaques are not visible) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/22,25\">",
"       22,25",
"      </a>",
"      ]. SSD has been nearly completely replaced by volume rendering.",
"     </li>",
"     <li>",
"      Volume rendering (VR) &ndash; VR assigns each pixel its own unique opacity and color. These opacity and color assignments are then used to create a three-dimensional image, which displays the surface and interior of a structure with tissue-like effects.",
"     </li>",
"     <li>",
"      Virtual reality (ie, perspective rendering or \"fly through\" imaging) is used for CT bronchoscopy and other endoluminal applications. It gives the viewer the perspective of being within the lumen. The attenuation values for the mucosa or endoluminal surface are highlighted by special algorithms [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     CT ANGIOGRAPHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT angiography is performed with a helical CT scan that lasts 15 to 30 seconds. The collimation, gantry rotation time, and duration of helix are set as described above. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Settings'",
"    </a>",
"    above.) The detector width is generally 0.5 to 2 mm and the pitch depends upon the type of CT angiogram being performed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During CT pulmonary angiography, the pitch is usually 1.5 to 2.0",
"     </li>",
"     <li>",
"      During CT coronary arteriography, the pitch is usually 0.23 to 0.25",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Optimal vascular enhancement with contrast material is essential for high quality CT angiography. In most cases, 100 to 160 mL of low or iso-osmolar contrast material (320 to 370 mg iodine per mL) are injected at a rate of 3 to 6 mL per second. A typical delay for CT pulmonary angiography is 15 to 20 seconds and for CT coronary arteriography is 20 to 30 seconds.",
"   </p>",
"   <p>",
"    The exact volume and rate of the contrast material injection are based upon the recirculation time or delay time, which can be estimated using either a timing bolus of 20 mL of contrast material injected at 5 mL per second or bolus tracking technology (a normal pulmonary recirculation time is 4 to 10 seconds and a normal systemic recirculation time is 12 to 20 seconds). Patients who have a short recirculation time (ie, a high cardiac output or large central blood volume) are administered a larger volume of contrast material at a higher rate. This increases vascular enhancement, mitigating the tendency of a high cardiac output to decrease vascular enhancement. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Intravenous contrast'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The helical data set is reconstructed into virtual axial sections using a reconstruction interval that provides 50 to 66 percent overlap. This facilitates a smooth, three-dimensional display without partial volume averaging.",
"   </p>",
"   <p>",
"    Axial source images followed by two-dimensional multiplanar reformations have the best spatial and contrast resolution. They are also the least susceptible to artifacts. The three-dimensional rendering techniques described above have been used to display CT angiograms, while two-dimensional rendering with retrospective ECG gating may improve visualization of the coronary arteries, especially with volumetric 64 to 320 slice CT scanners [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MULTISLICE HELICAL CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multislice helical CT is a major technical development in helical CT scanning [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/3-5,30-34\">",
"     3-5,30-34",
"    </a>",
"    ]. During multislice helical CT, a cone-shaped x-ray beam (wider collimation than the conventional fan-shaped x-ray beam) strikes many of the 16 to 320 detector rows that are arranged in parallel along the longitudinal axis (ie, the direction of the table motion). The combination of a cone-shaped x-ray beam and multiple rows of detectors allows a larger proportion of the x-ray beam to be used for imaging purposes (ie, the detective quantum efficiency is 11 to 22 percent instead of 5.5 percent), instead of being converted to heat. Multiple channels extract the data that are obtained simultaneously from different anatomic sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Benefits",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multislice helical CT scanners acquire data up to 64 times faster than single slice helical CT scanners. This is primarily a consequence of the simultaneous acquisition of 64 slices, since gantry rotation is only slightly faster (gantry rotation times are limited by the G-forces that are generated). Thus, multislice helical CT scanners can cover 64 times more patient length per unit time, the same patient length in a shorter time, or the same patient length in the same time with thinner slices, when compared to the original single slice helical scanners. Increasing the pitch can further increase the anatomic coverage or decrease the examination time. The entire chest can be scanned in less than ten seconds with a multislice helical CT scanner.",
"   </p>",
"   <p>",
"    Multislice helical CT has additional advantages, both technical and clinical, compared to single slice helical CT:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Its 360 degree reconstruction algorithm reduces signal noise by a factor of 1.4, compared to the 180 degree reconstruction algorithm that is used in single slice helical CT.",
"     </li>",
"     <li>",
"      Several hundred image slices are generated in 60 seconds or less, facilitating the visualization of image stacks. The abundant images are best viewed and manipulated on a PACS workstation rather than conventional film.",
"     </li>",
"     <li>",
"      Faster image acquisition results in fewer motion artifacts. Temporal resolution is not influenced by the number of detector rows, but is directly dependent upon the rotation speed of the gantry (ie, 270 to 500 msecs).",
"     </li>",
"     <li>",
"      The spatial resolution (ie, the ability to distinguish objects that are separate but close together) and z-axis resolution are both improved, thereby generating nearly isotropic voxels.",
"     </li>",
"     <li>",
"      Anatomic coverage is increased.",
"     </li>",
"     <li>",
"      Contrast enhancement is optimal, with enhanced conspicuity of vascular structures. This is particularly true of CT pulmonary angiography, CT aortography, and CT coronary arteriography.",
"     </li>",
"     <li>",
"      Enhanced image processing includes volume rendering, maximum intensity projections, shaded surface display, curved multiplanar reformation, and virtual reality imaging. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Three-dimensional'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Retrospective reconstructions can be performed without the need for additional data acquisition. Virtually any section thickness can be reconstructed, as long as the initial data set was acquired with a 0.5 mm to 0.625 mm detector width.",
"     </li>",
"     <li>",
"      The diagnostic accuracy of CT angiography is improved, with respect to the detection of aortic dissections, aneurysms, and pulmonary emboli in subsegmental arteries [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/35,36\">",
"       35,36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The detection and characterization of small pulmonary nodules is enhanced [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/37,38\">",
"       37,38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The visualization of airways disease (eg, bronchiectasis) is markedly improved.",
"     </li>",
"     <li>",
"      Assessment of the lung parenchyma using 1 mm collimation is just as detailed with multislice helical CT as high resolution CT. However, high resolution CT requires only 10 percent of the radiation dose that is required by multislice helical CT. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=see_link\">",
"       \"High resolution computed tomography of the lungs\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Display of the lungs in the coronal and sagittal planes facilitates better demonstration of the distribution of diffuse lung disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Technical parameters",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following parameters are unique to multislice helical CT. Other technical parameters for helical CT were described above. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Settings'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The number of data channels determines the number of images, rather than the number of detector rows (each data channel can correspond to several detector rows).",
"     </li>",
"     <li>",
"      Detector row width is the minimum thickness of a detector row element.",
"     </li>",
"     <li>",
"      Effective detector row thickness is the sum of the width of the detector rows for each data channel. This determines the section thickness.",
"     </li>",
"     <li>",
"      Detector configuration is determined by the number of channels per z-axis and the effective detector row thickness of each channel.",
"     </li>",
"     <li>",
"      Collimation is the product of the number of data channels and the effective detector row thickness.",
"     </li>",
"     <li>",
"      Table travel speed per second (ie, the table feed) is the product of the collimation, pitch, and rotations of the x-ray beam per second.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     ELECTRON BEAM CT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electron beam CT (also called ultrafast CT or fifth generation CT) uses an electron gun instead of an x-ray tube and detector array [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/1,39\">",
"     1,39",
"    </a>",
"    ]. The anode is bombarded by electrons, producing an x-ray beam that sweeps the patient (",
"    <a class=\"graphic graphic_figure graphicRef57585 \" href=\"UTD.htm?3/46/3823\">",
"     figure 4",
"    </a>",
"    ). Images are obtained in 50 to 100 milliseconds, virtually freezing motion. This technique is available in only a small number of centers and is used primarily for pediatric and cardiac applications:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Imaging the upper airways [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Imaging noncooperative children without sedation.",
"     </li>",
"     <li>",
"      Imaging the heart [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Imaging the coronary arteries, including detection of subtle coronary artery calcifications and calculation of a coronary calcium score. This evaluates the risk for future acute coronary events [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/41\">",
"       41",
"      </a>",
"      ]. The absence of calcifications makes coronary artery disease less likely. Multislice CT scanning can achieve similar or better results and has replaced electron-beam CT scanning for most applications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     RADIATION DOSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effective radiation dose for CT of the chest varies between 5 and 10 mSv, which is approximately 50 to 100 times more than chest radiography (0.1 mSv) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/42\">",
"     42",
"    </a>",
"    ]. Among the various CT scans, helical CT yields a radiation dose that is greater than that of conventional high resolution CT.",
"   </p>",
"   <p>",
"    To put this into context, all individuals are exposed to natural background radiation of approximately 3.6 mSv per year [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/43\">",
"     43",
"    </a>",
"    ]. The average population exposure in the United States has increased to 6 mSv per year, mainly due to CT scanning [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Studies of atomic bomb survivors from Japan suggest that the risk of developing cancer significantly increases when radiation exposure exceeds 50 mSv. Whether the risk of cancer is increased with less radiation exposure is uncertain and controversial.",
"   </p>",
"   <p>",
"    To minimize radiation exposure, CT of the chest can be performed using low radiation protocols, which provide effective radiation doses of only 0.5 to 1 mSv [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. In addition, CT should be used judiciously and overutilization avoided, in order to avoid the potential induction of radiogenic cancers [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17032/abstract/44,45\">",
"     44,45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Computed tomography (CT) is an imaging technique that has revolutionized medical imaging. It is widely available, fast, and provides a detailed view of the internal organs and structures. Helical CT is most common, but conventional step-and-shoot CT is used for thin section high resolution CT scanning of the lungs, coronary artery calcification scoring, and prospective ECG-gated coronary CT angiography. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The principal components of a CT scanner are the x-ray tube and a diametrically opposed array of detectors. The x-ray tube generates an x-ray beam as it rotates around the patient and the detectors concurrently record the radiation that traverses the body. The acquired data are digitized and then reconstructed into axial images. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General description'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CT is superior to conventional radiography because it has exquisite contrast resolution and its images do not have anatomic structures superimposed on one another. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Advantages'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Helical CT is superior to conventional step-and-shoot axial CT because it is faster and it minimizes respiratory misregistration and motion artifacts. In addition, helical CT can perform CT angiography and reformat high quality multiplanar two-dimensional and three-dimensional images. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Advantages'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Two-dimensional and three-dimensional rendering'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18\">",
"       'CT angiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several of the parameters used in CT are set by the operator. These include the collimation and detector width of the x-ray beam, pitch, the field of view, the duration of the helix, the reconstruction interval, and the reconstruction algorithm or kernel. Operators must also be familiar with proper breathing instructions and protocols for the injection of intravenous contrast. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Breathing instructions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Intravenous contrast'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multislice helical CT is a significant technical advancement in helical CT scanning. It has many advantages over conventional single slice helical CT. However, its major drawback is its high effective radiation dose. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Multislice helical CT'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H23\">",
"       'Radiation dose'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/1\">",
"      McCollough CH, Morin RL. The technical design and performance of ultrafast computed tomography. Radiol Clin North Am 1994; 32:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/2\">",
"      Brink JA, Heiken JP, Wang G, et al. Helical CT: principles and technical considerations. Radiographics 1994; 14:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/3\">",
"      Flohr TG, Schaller S, Stierstorfer K, et al. Multi-detector row CT systems and image-reconstruction techniques. Radiology 2005; 235:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/4\">",
"      Kalra MK, Maher MM, D'Souza R, Saini S. Multidetector computed tomography technology: current status and emerging developments. J Comput Assist Tomogr 2004; 28 Suppl 1:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/5\">",
"      Prokop M. General principles of MDCT. Eur J Radiol 2003; 45 Suppl 1:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/6\">",
"      Rubin GD. 3-D imaging with MDCT. Eur J Radiol 2003; 45 Suppl 1:S37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/7\">",
"      Rydberg J, Buckwalter KA, Caldemeyer KS, et al. Multisection CT: scanning techniques and clinical applications. Radiographics 2000; 20:1787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/8\">",
"      Slavin GS, Bluemke DA. Spatial and temporal resolution in cardiovascular MR imaging: review and recommendations. Radiology 2005; 234:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/9\">",
"      Zeman RK, Fox SH, Silverman PM, et al. Helical (spiral) CT of the abdomen. AJR Am J Roentgenol 1993; 160:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/10\">",
"      Kalender WA, Seissler W, Klotz E, Vock P. Spiral volumetric CT with single-breath-hold technique, continuous transport, and continuous scanner rotation. Radiology 1990; 176:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/11\">",
"      Crawford CR, King KF. Computed tomography scanning with simultaneous patient translation. Med Phys 1990; 17:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/12\">",
"      Vock P, Soucek M, Daepp M, Kalender WA. Lung: spiral volumetric CT with single-breath-hold technique. Radiology 1990; 176:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/13\">",
"      Heiken JP, Brink JA, Vannier MW. Spiral (helical) CT. Radiology 1993; 189:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/14\">",
"      Mountain CF. A new international staging system for lung cancer. Chest 1986; 89:225S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/15\">",
"      Brink JA, Heiken JP, Balfe DM, et al. Spiral CT: decreased spatial resolution in vivo due to broadening of section-sensitivity profile. Radiology 1992; 185:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/16\">",
"      Wang G, Vannier MW. Longitudinal resolution in volumetric x-ray computerized tomography--analytical comparison between conventional and helical computerized tomography. Med Phys 1994; 21:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/17\">",
"      Foley WD, Oneson SR. Helical CT: clinical performance and imaging strategies. Radiographics 1994; 14:894.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/18\">",
"      Kasales CJ, Hopper KD, Ariola DN, et al. Reconstructed helical CT scans: improvement in z-axis resolution compared with overlapped and nonoverlapped conventional CT scans. AJR Am J Roentgenol 1995; 164:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/19\">",
"      Tomiak MM, Foley WD, Jacobson DR. Variable-mode helical CT: imaging protocols. AJR Am J Roentgenol 1995; 164:1525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/20\">",
"      Rubin GD, Dake MD, Napel SA, et al. Three-dimensional spiral CT angiography of the abdomen: initial clinical experience. Radiology 1993; 186:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/21\">",
"      Rubin, GD, Costello, P. Three-dimensional spiral CT angiography. In: Radiology: Diagnosis, Imaging, and Intervention, Taveras, JM, Ferrucci, JT (Eds), Lippincott, Philadelphia, PA, 1994; 152:1-15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/22\">",
"      Rubin GD. Three-dimensional helical CT angiography. Radiographics 1994; 14:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/23\">",
"      Napel S, Marks MP, Rubin GD, et al. CT angiography with spiral CT and maximum intensity projection. Radiology 1992; 185:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/24\">",
"      Napel S, Rubin GD, Jeffrey RB Jr. STS-MIP: a new reconstruction technique for CT of the chest. J Comput Assist Tomogr 1993; 17:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/25\">",
"      Magnusson M, Lenz R, Danielsson PE. Evaluation of methods for shaded surface display of CT volumes. Comput Med Imaging Graph 1991; 15:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/26\">",
"      Rubin GD, Beaulieu CF, Argiro V, et al. Perspective volume rendering of CT and MR images: applications for endoscopic imaging. Radiology 1996; 199:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/27\">",
"      Napoli A, Fleischmann D, Chan FP, et al. Computed tomography angiography: state-of-the-art imaging using multidetector-row technology. J Comput Assist Tomogr 2004; 28 Suppl 1:S32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/28\">",
"      Brink JA. Contrast optimization and scan timing for single and multidetector-row computed tomography. J Comput Assist Tomogr 2003; 27 Suppl 1:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/29\">",
"      Achenbach S, Ulzheimer S, Baum U, et al. Noninvasive coronary angiography by retrospectively ECG-gated multislice spiral CT. Circulation 2000; 102:2823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/30\">",
"      Saini S. Multi-detector row CT: principles and practice for abdominal applications. Radiology 2004; 233:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/31\">",
"      Cody DD, Mahesh M. AAPM/RSNA physics tutorial for residents: Technologic advances in multidetector CT with a focus on cardiac imaging. Radiographics 2007; 27:1829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/32\">",
"      Entrikin DW. True high-definition in cardiac imaging will require 4 dimensions of technologic innovation. J Cardiovasc Comput Tomogr 2009; 3:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/33\">",
"      Berland LL, Smith JK. Multidetector-array CT: once again, technology creates new opportunities. Radiology 1998; 209:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/34\">",
"      Weg N, Scheer MR, Gabor MP. Liver lesions: improved detection with dual-detector-array CT and routine 2.5-mm thin collimation. Radiology 1998; 209:417.",
"     </a>",
"    </li>",
"    <li>",
"     Rubin GD, Kalra MK. MDCT Angiography of the thoracic aorta. In: MDCT from protocols to practice, Kalra MK, Saini S, Rubin GD (Eds), Springer Verlag, 2006. p.225.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/36\">",
"      Schoepf UJ, Holzknecht N, Helmberger TK, et al. Subsegmental pulmonary emboli: improved detection with thin-collimation multi-detector row spiral CT. Radiology 2002; 222:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/37\">",
"      Ahn MI, Gleeson TG, Chan IH, et al. Perifissural nodules seen at CT screening for lung cancer. Radiology 2010; 254:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/38\">",
"      Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009; 253:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/39\">",
"      Thompson BH, Stanford W. Evaluation of cardiac function with ultrafast computed tomography. Radiol Clin North Am 1994; 32:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/40\">",
"      Galvin JR, Gingrich RD, Hoffman E, et al. Ultrafast computed tomography of the chest. Radiol Clin North Am 1994; 32:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/41\">",
"      Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358:1336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/42\">",
"      Nickoloff EL, Lu ZF, Dutta AK, So JC. Radiation dose descriptors: BERT, COD, DAP, and other strange creatures. Radiographics 2008; 28:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/43\">",
"      Parry RA, Glaze SA, Archer BR. The AAPM/RSNA physics tutorial for residents. Typical patient radiation doses in diagnostic radiology. Radiographics 1999; 19:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/44\">",
"      Mettler FA Jr, Bhargavan M, Faulkner K, et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other radiation sources--1950-2007. Radiology 2009; 253:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/45\">",
"      Schauer DA, Linton OW. National Council on Radiation Protection and Measurements report shows substantial medical exposure increase. Radiology 2009; 253:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/46\">",
"      Amis ES Jr, Butler PF, Applegate KE, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol 2007; 4:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17032/abstract/47\">",
"      Mayo JR, Aldrich J, Muller NL, Fleischner Society. Radiation exposure at chest CT: a statement of the Fleischner Society. Radiology 2003; 228:15.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6982 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-DCF38A056D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17032=[""].join("\n");
var outline_f16_40_17032=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL DESCRIPTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Configuration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ADVANTAGES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SETTINGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Collimation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Pitch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Duration of the helix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Reconstruction interval",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Gantry rotation time",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      BREATHING INSTRUCTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      INTRAVENOUS CONTRAST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      DATA PROCESSING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      IMAGES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      TWO-DIMENSIONAL AND THREE-DIMENSIONAL RENDERING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Two-dimensional",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Three-dimensional",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      CT ANGIOGRAPHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MULTISLICE HELICAL CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Benefits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Technical parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      ELECTRON BEAM CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      RADIATION DOSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6982\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6982|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/20/36160\" title=\"diagnostic image 1\">",
"      Curved planar reformation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6982|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/61/23519\" title=\"figure 1\">",
"      Scanning geometry helical CT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/12/33999\" title=\"figure 2\">",
"      Helical scanning modes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/34/43566\" title=\"figure 3\">",
"      Linear interpolation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/46/3823\" title=\"figure 4\">",
"      Ultrafast CT scanner diagram",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/43/17080?source=related_link\">",
"      Computed tomographic and positron emission tomographic scanning of pulmonary nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/32/18950?source=related_link\">",
"      Computed tomography of the hepatobiliary tract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/29/16858?source=related_link\">",
"      High resolution computed tomography of the lungs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/26/20906?source=related_link\">",
"      Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=related_link\">",
"      Role of imaging in the staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_40_17033="Epidural abscess";
var content_f16_40_17033=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidural abscess",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17033/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17033/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17033/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17033/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17033/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17033/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/40/17033/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidural abscess is a rare but important suppurative infection of the central nervous system (CNS). Abscesses that are enclosed within the bony confines of the skull or spinal column can expand to compress the brain or spinal cord and cause severe symptoms, permanent complications, or even death. Prompt diagnosis and proper treatment can avert complications and achieve cure in many cases. Both the diagnosis and management of epidural abscess, which often includes a surgical procedure for aspiration or drainage of the abscess, have been greatly aided by the advent of modern imaging techniques, such as computed tomography (CT) and especially magnetic resonance imaging (MRI) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two distinct varieties of epidural abscess occur: spinal epidural abscess (SEA) and intracranial epidural abscess (IEA). SEA is more common by a factor of nine to one. The distinction between these two entities is based upon the different anatomy of the two locations within the CNS, and some differences in symptoms and natural history.",
"   </p>",
"   <p>",
"    The epidemiology, microbiology, clinical manifestations, diagnosis, and treatment of epidural abscess will be reviewed here. Brain abscess and bacterial meningitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38104?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of brain abscess\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32438?source=see_link\">",
"     \"Treatment and prognosis of brain abscess\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/38/31335?source=see_link\">",
"     \"Epidemiology of bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/41/38549?source=see_link\">",
"     \"Pathogenesis and pathophysiology of bacterial meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=see_link\">",
"     \"Treatment of bacterial meningitis caused by specific pathogens in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18280?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SPINAL EPIDURAL ABSCESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal epidural abscess (SEA) requires prompt recognition and proper management to avoid potentially disastrous complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomy of the spinal canal and dura mater determines many features of epidural abscesses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/3\">",
"     3",
"    </a>",
"    ]. For example, the dura is adherent to the bone above the foramen magnum. In contrast, an actual or true epidural space exists below the foramen magnum posterior and lateral to the spinal cord that extends down the length of the spinal canal (",
"    <a class=\"graphic graphic_figure graphicRef51884 \" href=\"UTD.htm?16/14/16612\">",
"     figure 1",
"    </a>",
"    ). This space is small in the cervical region and larger in the sacral region. The epidural space contains fat as well as arteries and a venous plexus. SEAs are more common in the thoracolumbar areas, where the epidural space is larger and contains more infection-prone fat tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/1,5,6\">",
"     1,5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only a potential epidural space exists anterior to the cord because the dura is adherent to the vertebral bodies from the foramen magnum down to L1. As a result, the majority of SEAs are located posteriorly; when anterior SEAs occur, they are usually below L1. Because the epidural space is a vertical sheath, abscesses that begin at one level commonly extend to multiple levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bacteria can gain access to the epidural space hematogenously by direct extension from infected contiguous tissue (such as a vertebral body or psoas muscle) or via direct inoculation into the spinal canal (eg, during spinal or epidural anesthetic procedures or surgery).",
"   </p>",
"   <p>",
"    Many SEAs begin as a focal pyogenic infection involving the vertebral disc or the junction between the disc and the vertebral body (pyogenic infectious discitis) (",
"    <a class=\"graphic graphic_figure graphicRef51884 \" href=\"UTD.htm?16/14/16612\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As the pyogenic inflammation progresses and the abscess extends longitudinally in the epidural space, damage to the spinal cord can be caused by any one or more of the following mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Direct compression",
"     </li>",
"     <li>",
"      Thrombosis and thrombophlebitis of nearby veins",
"     </li>",
"     <li>",
"      Interruption of the arterial blood supply",
"     </li>",
"     <li>",
"      Bacterial toxins and mediators of inflammation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Longitudinal extension is common when infection arises in the epidural space. The average extent is three to five spinal cord segments [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/5\">",
"     5",
"    </a>",
"    ], but the whole length of the spinal column may be involved. However, even a small SEA can cause severe neurologic symptoms and sequelae.",
"   </p>",
"   <p>",
"    Epidural abscesses may contain frank pus, especially in acute cases, but it is quite common to find only granulation tissue at the time of surgical drainage. Granulation tissue is often present when abscesses have been present for more than two weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although SEA is an uncommon disease, occurring in only 2 to 25 patients per 100,000 admitted to the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/3\">",
"     3",
"    </a>",
"    ], there is evidence that the incidence may have increased over the last 30 years. Part of this increase may relate to the fact that the sensitivity and accuracy of diagnosis has been improved by the use of magnetic resonance imaging (MRI) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/9\">",
"     9",
"    </a>",
"    ]. The increasing incidence of SEA may also relate to the aging of the United States&rsquo; population and increases in the number of patients undergoing invasive spinal procedures for anesthesia or pain control.",
"   </p>",
"   <p>",
"    One population-based study of the incidence of spontaneous epidural abscess has been published. During the period 1990 to 2000, the incidence in a county in Minnesota was 0.88",
"    <span class=\"nowrap\">",
"     case/100,000",
"    </span>",
"    person-years (95% CI 0.27-1.48) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Epidural catheter placement is an important risk factor for SEA. The reported incidence of epidural abscesses following placement of epidural catheters has ranged from 0.5 to 3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. Reports that cite lower complication rates have not described the methods used for serial follow-up of patients undergoing this medical procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/15\">",
"     15",
"    </a>",
"    ]. The risk of epidural abscess is substantially lower when catheters are placed for short time periods, as occurs in obstetrical anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/16\">",
"     16",
"    </a>",
"    ]. In a review of 506,000 pregnant women undergoing epidural catheter placement in 203 obstetric units in the United Kingdom, only one SEA occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Paraspinal injections of glucocorticoids or analgesics can also be complicated by the subsequent development of an epidural abscess [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other possible risk factors for SEA include [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/18\">",
"     18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diabetes mellitus",
"     </li>",
"     <li>",
"      Alcoholism",
"     </li>",
"     <li>",
"      HIV infection",
"     </li>",
"     <li>",
"      Trauma",
"     </li>",
"     <li>",
"      Tattooing",
"     </li>",
"     <li>",
"      Acupuncture",
"     </li>",
"     <li>",
"      Contiguous bony or soft tissue infection",
"     </li>",
"     <li>",
"      Bacteremia, secondary to distant infection",
"     </li>",
"     <li>",
"      Intravenous drug abuse",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The median age of onset of SEA is approximately 50 years and the prevalence appears to be greatest between age 50 and 70 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/19\">",
"     19",
"    </a>",
"    ], but SEA can occur at any age. The incidence has been higher in males in some studies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Microbiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The leading bacterial pathogen causing SEA is Staphylococcus aureus, which accounts for about two-thirds of cases caused by pyogenic bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/1-3,5,20\">",
"     1-3,5,20",
"    </a>",
"    ]. Various other bacteria can also produce the infection. The approximate frequency of the leading causes of SEA (excluding mycobacteria) is as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      S. aureus &mdash; 63 percent",
"     </li>",
"     <li>",
"      Gram-negative bacilli &mdash; 16 percent",
"     </li>",
"     <li>",
"      Streptococci &mdash; 9 percent",
"     </li>",
"     <li>",
"      Coagulase-negative staphylococci &mdash; 3 percent, mostly occurring in patients with prior spinal instrumentation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Anaerobes &mdash; 2 percent",
"     </li>",
"     <li>",
"      Others (eg, fungi, parasites) &mdash; 1 percent",
"     </li>",
"     <li>",
"      Unknown &mdash; 6 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mycobacterium tuberculosis is likely to be a more frequent cause of epidural abscesses in parts of the developing world [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=see_link\">",
"     \"Skeletal tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The proportion of S. aureus infections that are methicillin-resistant (MRSA) is steadily rising; at one institution, MRSA comprised 40 percent of all S. aureus SEAs [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/18\">",
"     18",
"    </a>",
"    ]. In another case series, 21 of 31 patients with staphylococcal epidural abscesses were infected with MRSA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Portals of entry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-third of patients with SEA have no identifiable source for the infection. Among the two-thirds for whom a portal of entry can be identified, the most common sites of origin are infections of skin and soft tissues and complications of spinal surgery or other invasive procedures, including epidural catheters that are left in place, usually for pain control (",
"    <a class=\"graphic graphic_table graphicRef51340 \" href=\"UTD.htm?38/51/39739\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    SEA from epidural catheters can result from contamination at the time the catheter is inserted; ascending contamination of the catheter from normal skin flora following catheter insertion; from injection using contaminated syringes or local anesthetic solutions; or by hematogenous seeding from a bacteremia that occurs while the catheter is in place [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The importance of infection control measures to prevent epidural abscesses associated with epidural catheters was illustrated by a report in which the infecting organism was subsequently isolated from nasal swabs taken from the physician who placed the catheter [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/24\">",
"     24",
"    </a>",
"    ]. This finding has prompted the recommendation to use face masks when epidural catheters are placed. Also, safe injection practices must be used during spinal injection procedures in order to prevent bacterial contamination of medication vials (",
"    <a class=\"external\" href=\"file://www.cdc.gov/injectionsafety/\">",
"     file://www.cdc.gov/injectionsafety/",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Injection drug abuse is also an occasional predisposing factor. Up to one-third of cases of epidural abscess may arise from hematogenous infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial manifestations of SEA are often nonspecific, and include such signs and symptoms as fever and malaise. The classical diagnostic triad consists of fever, spinal pain, and neurologic deficits. However, only a few patients have all three components at presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/25\">",
"     25",
"    </a>",
"    ]. Fever may be absent in some patients, leading to delayed or missed diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/22\">",
"     22",
"    </a>",
"    ]. Over time, however, an untreated abscess causes symptoms that progress in a typical sequence [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Back pain, which is often focal and severe, then",
"     </li>",
"     <li>",
"      Root pain, described as \"shooting\" or \"electric shocks\" in the distribution of the affected nerve root, then",
"     </li>",
"     <li>",
"      Motor weakness, sensory changes, and bladder or bowel dysfunction, and then",
"     </li>",
"     <li>",
"      Paralysis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Once paralysis develops, it may quickly become irreversible. Thus, urgent intervention may be required if progression of weakness or other neurologic findings are suspected or detected [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thinking of SEA is the key to diagnosis. SEA is a rare cause of back pain, even though most patients with SEA have back pain. Thus, it is not surprising that the diagnosis is infrequently made, or even considered, when patients with this condition first seek medical care. A minority of patients with SEA in three case series had the classic triad of fever, spinal pain, and neurologic deficits at the time they initially sought medical care [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/22,25,28\">",
"     22,25,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fever was the most likely classic finding to be absent in these case series; as an example, only 23 of 48 patients were febrile in one case series reported from a single tertiary care center [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/28\">",
"     28",
"    </a>",
"    ]. However, fever is an important diagnostic clue when it is present. It is important to note that fever is not typically present in most patients with herniated discs or other causes of musculoskeletal back pain. Fever in a patient with severe, localized back pain, especially if the pain is worsened by percussion, should suggest the diagnosis of SEA or vertebral osteomyelitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/28/22985?source=see_link\">",
"     \"Vertebral osteomyelitis and discitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The difficulty in establishing the diagnosis of SEA was investigated in a study of 63 patients presenting to the emergency department (ED) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/25\">",
"     25",
"    </a>",
"    ]. The mean duration of symptoms between onset and the first ED visit or admission was five and nine days, respectively, and the median number of ED visits before admission was two (range one to eight). Compared with 126 matched controls with spine pain, one or more features of the classic triad of SEA were present in 98 percent of patients compared with only 21 percent of controls.",
"   </p>",
"   <p>",
"    The same group of investigators subsequently reported that diagnostic delays were significantly less common during a five-year study period after a decision guideline was developed for all patients who sought care for spinal pain [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/29\">",
"     29",
"    </a>",
"    ]. The decision guideline included a risk factor assessment for all patients initially lacking neurologic deficits followed by erythrocyte sedimentation rate (ESR) and C-reactive protein measurements prior to obtaining imaging studies. The risk factor assessment included obtaining information about the following factors: diabetes, history of intravenous drug use, chronic liver or kidney disease, recent spine procedures, spinal surgery or fractures, indwelling vascular catheters, other site of infection, or an immunocompromising condition. Diagnostic delay was defined as multiple visits to the ED or admission to a nonsurgical service without a diagnosis of SEA. Diagnostic delays were observed in 46 of 55 patients (84 percent) during a nine-year period prior to the institution of this decision guideline, compared with 3 of 31 patients (10 percent) during the five year period following the use of the above decision guideline.",
"   </p>",
"   <p>",
"    Routine laboratory studies are seldom helpful in the diagnosis of SEA. The ESR is usually elevated in both SEA and vertebral osteomyelitis, the hematocrit is usually normal, and the leukocyte count may be elevated or normal. In the ED patient population described above, only 60 percent of patients who were diagnosed with SEA had leukocytosis at their initial visit [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/25\">",
"     25",
"    </a>",
"    ]. In another prospective study, the ESR was elevated (&gt;20",
"    <span class=\"nowrap\">",
"     mm/hour)",
"    </span>",
"    in all 86 patients with SEA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/29\">",
"     29",
"    </a>",
"    ]. In contrast, only 33 percent of non-SEA patients had ESR elevations. The mean ESR in patients with SEA was significantly elevated (76.5",
"    <span class=\"nowrap\">",
"     mm/hour).",
"    </span>",
"   </p>",
"   <p>",
"    In another report, the ESR was elevated in 110 of 117 patients (94 percent) of patients with SEA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/30\">",
"     30",
"    </a>",
"    ]. The utility of C-reactive protein in patients with SEA in this series was less striking: 87 percent of patients with SEA had elevated levels, as compared to 50 percent of patients with spine pain not due to a SEA. &nbsp;",
"   </p>",
"   <p>",
"    Once the diagnosis of SEA is seriously considered, imaging of the spinal column is imperative. MRI is the preferred test because it is often positive early in the course of the infection and provides the best imaging of the location and extent of inflammatory changes (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef68878 \" href=\"UTD.htm?34/0/34817\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/20,31\">",
"     20,31",
"    </a>",
"    ]. Computed tomography (CT) scanning with intravenous contrast is an acceptable alternative [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/5,32\">",
"     5,32",
"    </a>",
"    ]. Plain radiographs of the spine may reveal changes of osteomyelitis or discitis, but are rarely diagnostic of SEA. Myelography is now largely obsolete.",
"   </p>",
"   <p>",
"    Once an intraspinal mass that could be an SEA has been located, it is important to try to isolate the etiologic organism from samples of blood, abscess contents, or cerebrospinal fluid (CSF) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/3\">",
"     3",
"    </a>",
"    ]. The approximate frequency of positive cultures from these sources in SEA is [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abscess contents &mdash; 90 percent",
"     </li>",
"     <li>",
"      Blood &mdash; 62 percent",
"     </li>",
"     <li>",
"      CSF &mdash; 19 percent positive (but Gram stain of CSF is almost always negative [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/5\">",
"       5",
"      </a>",
"      ])",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Two blood cultures should be drawn. The best specimen for culture is fluid or pus obtained by direct needle aspiration, usually under CT guidance, of the epidural abscess or inflammatory mass. Lumbar puncture for CSF examination is often not performed, because the diagnostic yield is low. In most cases the CSF findings are limited to a nonspecific elevation of protein and pleocytosis. CSF Gram stain is usually negative, and cultures are rarely positive [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/5,18\">",
"     5,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of SEA is extensive because many conditions cause back pain and neurologic deficits. Important entities to consider include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Disc and degenerative bone disease",
"     </li>",
"     <li>",
"      Metastatic tumors",
"     </li>",
"     <li>",
"      Vertebral discitis and osteomyelitis",
"     </li>",
"     <li>",
"      Meningitis",
"     </li>",
"     <li>",
"      Herpes zoster, prior to the appearance of skin lesions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is important to realize that S. aureus is a common cause of osteomyelitis and discitis as well as SEA; the combination of back pain and S. aureus bacteremia is not specific to SEA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The common causes of low back pain in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two principles of optimal therapy of an SEA are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reduction in size and ultimate elimination of the inflammatory mass",
"     </li>",
"     <li>",
"      Eradication of the causative organism",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These goals are usually accomplished by a combination of aspiration, drainage, and antibiotic therapy. A team approach involving internists, neurologists, infectious diseases specialists, radiologists, and orthopedists",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neurosurgeons gives the best results.",
"   </p>",
"   <p>",
"    In most cases, early surgical decompression and drainage, preferably within the first 24 hours after the patient reaches the hospital, is the critical factor that will improve the ultimate prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/20,27\">",
"     20,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Conservative versus surgical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of MRI has enabled the diagnosis of SEA in an increasing proportion of patients while the abscess is still small and has not yet impinged on the spinal cord. Although surgical decompression and drainage with systemic antibiotic therapy is the treatment of choice for most patients, there are several reasons why medical therapy may be selected in patients in patients with documented epidural abscesses. Some patients may elect a non-surgical approach due to underlying medical conditions (eg, advanced malignancy); others may have advanced neurologic deficits that are deemed unlikely to improve with surgery.",
"   </p>",
"   <p>",
"    There are increasing numbers of reports documenting recovery in patients with epidural abscesses following simple aspiration (for diagnosis) and the use of antibiotic therapy without surgical decompression [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/33\">",
"     33",
"    </a>",
"    ]. In most of these cases, the abscess was either not associated with any neurologic deficit or accompanied by minor weakness at the time of diagnosis and initiation of treatment.",
"   </p>",
"   <p>",
"    The potential efficacy of this approach was illustrated in a retrospective analysis of 57 patients with SEA treated with either medical therapy alone or medical therapy combined with surgery between 1988 and 2002 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/34\">",
"     34",
"    </a>",
"    ]. There were no significant differences in the rates of complete recovery in the medical therapy group (76 percent) compared with the surgical group (57 percent). Success with medical therapy was unrelated to age, neurologic abnormality at presentation, or abscess size. However, patients with a moderate or severe neurologic deficit at presentation were more likely to have a poor outcome and may have benefitted from emergency surgical decompression. Successful outcomes with medical therapy were also noted in a second series of 38 patients in whom the causative microorganism was recovered from cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In another case series, 23 of 48 patients with epidural abscesses were initially treated medically [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/28\">",
"     28",
"    </a>",
"    ]. Eleven of these 23 patients deteriorated and required subsequent surgery. Overall, patients treated medically had a significantly worse outcome than those who were treated with immediate surgery. However, for reasons cited above, patients in the medical treatment group were substantially different than those who immediately underwent surgery. Furthermore, patients treated medically were quite diverse; many had serious underlying problems that resulted in a decision to initially forego surgery.",
"   </p>",
"   <p>",
"    Caution should be employed in interpreting data, such as those cited above, in making decisions about individual patients. Case series and case reports about favorable outcomes from medical therapy of SEA are selectively reported. Unsuccessful attempts at conservative therapy are less likely to be reported. Furthermore, patients undergoing medical therapy for SEA are heterogeneous in terms of their underlying medical problems and in the individual reasons why surgery is judged to be unnecessary or unwise.",
"   </p>",
"   <p>",
"    We use a conservative approach in selected patients in whom the organism is known from blood cultures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    aspiration and in whom there is no neurologic deficit. Medical therapy may also be appropriate in the rare patient who refuses surgery or is deemed to have an unacceptable surgical risk. Only a few patients meet these criteria.",
"   </p>",
"   <p>",
"    In addition to antibiotic therapy, a conservative approach includes the following steps:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A careful neurologic monitoring strategy is identified prior to initiating treatment",
"     </li>",
"     <li>",
"      A follow-up MRI should be performed to confirm diminishing size or resolution of the abscess",
"     </li>",
"     <li>",
"      Immediate surgery is warranted if neurologic deterioration occurs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Medical therapy is also acceptable in patients with complete paralysis present for more than 36 to 48 hours before a diagnosis of SEA has been made [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Antimicrobial therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H194640138\">",
"    <span class=\"h4\">",
"     Empiric therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An empiric regimen with antibiotics active against staphylococci, streptococci, and gram-negative bacilli should be chosen. Antibiotics should be directed against the known pathogen if the culture",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    Gram stain of the aspirate is positive. If an aspirate cannot be obtained, the empiric regimen should be continued.",
"   </p>",
"   <p>",
"    Appropriate empiric parenteral regimens include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      (30 to 60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      IV daily in two equally divided doses adjusted for renal function) for empiric coverage of MRSA and for use in patients who are allergic to penicillin. If susceptibility testing reveals methicillin-sensitive S. aureus (MSSA), vancomycin should be replaced with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/36/1608?source=see_link\">",
"       nafcillin",
"      </a>",
"      (2 g IV every four hours) OR",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"       oxacillin",
"      </a>",
"      (2 g IV every four hours) in patients without allergy to these agents since they have better central nervous system (CNS) penetration than vancomycin.",
"      <br/>",
"      <br/>",
"      <strong>",
"       PLUS",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"       Metronidazole",
"      </a>",
"      (500 mg IV or orally every eight hours)",
"      <br/>",
"      <br/>",
"      <strong>",
"       PLUS",
"      </strong>",
"     </li>",
"     <li>",
"      Either",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"       cefotaxime",
"      </a>",
"      (2 g IV every six hours),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (2 g IV every 12 hours), or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"       ceftazidime",
"      </a>",
"      (2 g IV every 8 hours). Ceftazidime is preferable when Pseudomonas aeruginosa is considered a possible or likely pathogen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H194640119\">",
"    <span class=\"h4\">",
"     Subsequent treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the etiologic agent or agents have been identified by culture, treatment regimens should be simplified and directed to that pathogen or those pathogens. Specific regimens for bacterial meningitis are discussed separately; similar antibiotic regimens can generally be used for bacterial meningitis and epidural abscesses, although epidural abscesses require a longer duration of therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=see_link\">",
"     \"Treatment of bacterial meningitis caused by specific pathogens in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H194640152\">",
"    <span class=\"h5\">",
"     MRSA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given substantial rates of MRSA infections,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    (30 to 60",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in two or three divided doses IV if renal function is normal) should be used as initial therapy when S. aureus is suspected or proven [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. If susceptibility testing reveals MSSA, therapy should be changed to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/36/1608?source=see_link\">",
"     nafcillin",
"    </a>",
"    (2 g IV every four hours) or&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/15/8437?source=see_link\">",
"     oxacillin",
"    </a>",
"    (2 g IV every four hours). If the organism is methicillin-resistant, vancomycin should be continued and dosed to achieve serum trough concentrations of 15 to 20",
"    <span class=\"nowrap\">",
"     mcg/mL.",
"    </span>",
"    A significant drawback to vancomycin is its poor penetration into the CSF of approximately 1 and 5 percent in uninflamed and inflamed meninges, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/36-39\">",
"     36-39",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     Rifampin",
"    </a>",
"    can be added to vancomycin at a dose of 600 mg orally once daily or 300 to 450 mg twice daily because it achieves bactericidal concentrations in the CSF regardless of meningeal inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/35,36,40\">",
"     35,36,40",
"    </a>",
"    ], although there are few data to support this [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. &nbsp;",
"    <br/>",
"    <br/>",
"    Based upon case reports and case series of patients with CNS infections caused by MRSA, alternatives to vancomycin include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     linezolid",
"    </a>",
"    (600 mg IV or orally twice daily) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/44-47\">",
"     44-47",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV every 8 to 12 hours) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/36,48,49\">",
"     36,48,49",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/10/20646?source=see_link\">",
"     daptomycin",
"    </a>",
"    (6",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    IV once daily) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. Although there are insufficient data regarding the efficacy of these regimens for the treatment of CNS infections caused by MRSA, these agents are reasonable alternatives when vancomycin cannot be used or is ineffective. Further studies are needed to establish the benefit of these agents for the treatment of CNS infections. This is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=see_link&amp;anchor=H108515050#H108515050\">",
"     \"Treatment of bacterial meningitis caused by specific pathogens in adults\", section on 'Staphylococcus aureus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H640150706\">",
"    <span class=\"h4\">",
"     Duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual duration of therapy is six to eight weeks, or until resolution of the SEA on MRI. The first follow-up MRI is obtained at about four to six weeks if the patient is improving, or at any time if clinical deterioration occurs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;About 5 percent of patients with SEA die, due to uncontrolled sepsis or other complications [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Irreversible paraplegia occurs in 4 to 22 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/1,5,18,52,53\">",
"     1,5,18,52,53",
"    </a>",
"    ]. Neurologic recovery is unlikely if paralysis is present for more than 24 hours prior to surgery. In other patients, the degree of neurologic recovery after surgery is related to the duration of the neurologic deficit. In the population of ED patients described above, 23 of 63 patients with an SEA had residual motor weakness [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/25\">",
"     25",
"    </a>",
"    ]. A delay to diagnosis (defined as multiple ED visits before diagnosis, admission without a diagnosis, or more than a 24 hour delay in performance of a definitive study) was associated with an increased risk of residual weakness compared with no diagnostic delay (45 versus 13 percent).",
"   </p>",
"   <p>",
"    There are limited data on the long-term post-treatment outcome of patients with neurologic deficits due to SEA. The authors of a report of the long-term outcome of 29 patients admitted to a tertiary care spine center with neurologic deficits due to SEA suggest that some patients show marked to moderate delayed improvement in their motor function following completion of rehabilitation treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     INTRACRANIAL EPIDURAL ABSCESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracranial epidural abscesses (IEAs) are less common than spinal epidural abscess (SEAs), and less acute in their evolution. However, like SEAs, these are major infections requiring optimal therapy to prevent complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The intracranial dura mater forms the inner lining of the skull and is directly adherent to bone. Thus, under normal circumstances, there is no actual epidural space. The potential epidural space can be opened by pressure from expanding tumors, blood, inflammatory masses, or pus. This requires that the firmly adherent dura be dissected off the bone; as a result, IEAs tend to be slow-growing, rounded, and well-localized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pathogenesis and pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Organisms usually spread into the potential extradural space by direct extension from a contiguous focus of infection or by inoculation during trauma or neurosurgery. After reaching this site, the bacteria cause inflammation and the formation of pus or granulation tissue, which gradually dissect the tough and adherent dura away from the inner table of the skull.",
"   </p>",
"   <p>",
"    IEAs usually consist of a localized lesion with a central collection of pus surrounded by a wall of inflammatory reaction (which may calcify). They rarely spread downwards (caudal) from inside the skull out into the spinal canal because the dura is very tightly attached around the foramen magnum. These findings are different from SEAs in which granulation tissue rather than pus is a common finding and longitudinal spread of infection is virtually the rule.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;IEA is the third most common focal intracranial infection, after brain abscess and subdural empyema. However, it accounts for only about one in ten cases of epidural abscesses, the other nine being SEAs. In the past, most cases were associated with sinusitis, otitis, or mastoiditis. Today, many cases arise as a complication of neurosurgical procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Microbiology and portals of entry",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usual portal of entry is from the exterior. If the inciting infection arises from the paranasal sinuses or ears, the organisms are likely to be microaerophilic or anaerobic streptococci",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other anaerobes such as Propionibacterium and Peptostreptococcus species. A few cases are due to aerobic gram-negative bacilli or fungi.",
"   </p>",
"   <p>",
"    If infection follows neurosurgery, the most likely organisms are staphylococci, especially S. aureus, and gram-negative bacteria. Infection can also spread inward from osteomyelitis of the skull or be introduced by fetal monitoring probes applied to the skull during birth.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Clinical manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Signs and symptoms develop both as a result of infection and the slowly-expanding intracranial mass. The latter can eventually cause raised intracranial pressure, papilledema, and, in some cases, focal neurologic signs. Fever, headache, lethargy, nausea, and vomiting are common. IEAs complicating sinus infections can cause purulent drainage from the nose or ear [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because an IEA usually arises as a complication of another process, the primary infection may become the focus of attention and delay diagnosis of the intracranial extension. As an example, local swelling and tenderness may be attributed to recent trauma, neurosurgery, or sinusitis, when in fact it overlies an IEA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The key to diagnosis is to consider this rare condition, then to perform a physical examination followed by appropriate imaging. Magnetic resonance imaging (MRI) usually provides more information than computed tomography (CT). CT-guided needle aspiration or open drainage can provide material for staining and culture for bacteria, mycobacteria, and fungi (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69915 \" href=\"UTD.htm?5/46/5856\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    An IEA can mimic any intracranial mass lesion, including parenchymal primary and metastatic tumors, meningiomas, hematomas, brain abscesses, or subdural empyemas. Chronic meningitis, tuberculous meningitis, or cranial arteritis should also be considered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful treatment of an IEA requires a combination of a drainage procedure and antibiotic therapy. Neurosurgical drainage is usually required, via burr holes or a craniotomy. If the dura is macerated or breached, a fascial graft may be applied.",
"   </p>",
"   <p>",
"    Sinus-related IEA in children may be managed without neurosurgical procedures in the setting of adequate sinus drainage and minimal mass effect from the abscess. This was illustrated in a study of eight children that compared a neurosurgical drainage procedure to sinus drainage without an intracranial procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17033/abstract/55\">",
"     55",
"    </a>",
"    ]. Patients received antibiotic therapy with activity against the isolated organism(s). All patients had clinical and radiologic resolution of infection with treatment.",
"   </p>",
"   <p>",
"    Empiric antibiotic therapy should be chosen based upon the probable origin of the infection. If contiguous infection of the paranasal sinuses, ear, or mastoid is the source, a regimen that is active against streptococci, Haemophilus species, and anaerobes should be chosen. The regimens listed above for treatment of SEA when the etiology is unknown are also appropriate for IEA. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Antimicrobial therapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    More specific antibiotic therapy should be given after the results of stains and cultures indicate the organism(s). With appropriate antibiotic and surgical management, the prognosis for IEA is good, with an attributable mortality below 10 percent. (See",
"    <a class=\"local\" href=\"#H194640119\">",
"     'Subsequent treatment'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H559982872\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidural abscess is a rare but important suppurative infection of the central nervous system (CNS). Abscesses that are enclosed within the bony confines of the skull or spinal column can expand to compress the brain or spinal cord and cause severe symptoms, permanent complications, or even death. Prompt diagnosis and proper treatment can avert complications and achieve cure in many cases. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258182987\">",
"    <span class=\"h2\">",
"     Spinal epidural abscess",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bacteria can gain access to the epidural space hematogenously, by direct extension from infected contiguous tissue (such as a vertebral body or psoas muscle), or via direct inoculation into the spinal canal (eg, during spinal or epidural anesthetic procedures or surgery). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for spinal epidural abscesses (SEAs) include epidural catheters, diabetes mellitus, alcoholism, HIV infection, bacteremia, and intravenous drug abuse. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Staphylococcus aureus is responsible for two-thirds of cases caused by pyogenic bacteria; less common causes include gram-negative bacilli, coagulase-negative staphylococci, streptococci, and anaerobes. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Approximately one-third of patients with SEA have no identifiable source for the infection. Among the two-thirds for whom a portal of entry can be identified, the most common sites of origin are infections of skin and soft tissues and complications of spinal surgery or other invasive procedures, including epidural catheters that are left in place, usually for pain control (",
"      <a class=\"graphic graphic_table graphicRef51340 \" href=\"UTD.htm?38/51/39739\">",
"       table 1",
"      </a>",
"      ). Injection drug abuse is also an important predisposing factor. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Portals of entry'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial manifestations of SEA can be nonspecific, such as fever and malaise. The classical diagnostic triad consists of fever, spinal pain, and neurologic deficits. However, only a few patients have all three components at presentation. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thinking of SEA is the key to diagnosis. SEA is a rare cause of back pain. Thus, it is not surprising that the diagnosis is infrequently made, or even considered, when patients with this condition first seek medical care. Once the diagnosis of SEA is seriously considered, imaging of the spinal column is imperative. Magnetic resonance imaging (MRI) is the preferred test because it is often positive early in the course of the infection and provides the best imaging of the location and extent of inflammatory changes (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef68878 \" href=\"UTD.htm?34/0/34817\">",
"       image 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once an intraspinal mass that could be an SEA has been located, it is important to try to isolate the etiologic organism from samples of blood, abscess contents, or cerebrospinal fluid. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The two principles of optimal therapy of an SEA are:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Reduction in size and ultimate elimination of the inflammatory mass",
"     </li>",
"     <li>",
"      Eradication of the causative organism",
"      <br/>",
"      <br/>",
"      These goals are usually accomplished by a combination of aspiration, drainage, and antibiotic therapy. In most cases, early surgical decompression and drainage, preferably within the first 24 hours after the patient reaches the hospital, is the critical factor that will improve the ultimate prognosis. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We use a conservative (non-surgical) approach in selected patients in whom the organism is known from blood cultures",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      aspiration and in whom there is no neurologic deficit. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Conservative versus surgical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend empiric regimen with antibiotics active against staphylococci, streptococci, and gram-negative bacilli. An appropriate regimen is",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      <strong>",
"       plus",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"       metronidazole",
"      </a>",
"      <strong>",
"       plus",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/57/35735?source=see_link\">",
"       cefotaxime",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"       ceftazidime",
"      </a>",
"      ; the latter agent should be used if Pseudomonas aeruginosa is a possible or likely pathogen. (See",
"      <a class=\"local\" href=\"#H194640138\">",
"       'Empiric therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When the etiologic agent or agents have been identified by culture, treatment regimens should be simplified and directed to that pathogen or those pathogens. (See",
"      <a class=\"local\" href=\"#H194640119\">",
"       'Subsequent treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The usual duration of therapy is six to eight weeks, or until resolution of the SEA on MRI. The first follow-up MRI is obtained at about four to six weeks if the patient is improving, or at any time if clinical deterioration occurs. (See",
"      <a class=\"local\" href=\"#H640150706\">",
"       'Duration'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258183069\">",
"    <span class=\"h2\">",
"     Intracranial epidural abscesses",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intracranial epidural abscesses (IEAs) are less common than SEAs, and less acute in their evolution. Organisms usually spread into the potential extradural space by direct extension from a contiguous focus of infection or by inoculation during trauma or neurosurgery. In the past, most cases were associated with sinusitis, otitis, or mastoiditis. Today, many cases arise as a complication of neurosurgical procedures. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Intracranial epidural abscess'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the inciting infection arises from the paranasal sinuses or ears, the organisms are likely to be microaerophilic or anaerobic streptococci",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      other anaerobes such as Propionibacterium and Peptostreptococcus species. If infection follows neurosurgery, the most likely organisms are staphylococci, especially S. aureus, and gram-negative bacteria. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Microbiology and portals of entry'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Signs and symptoms develop both as a result of infection and the slowly-expanding intracranial mass. The latter can eventually cause raised intracranial pressure, papilledema, and, in some cases, focal neurologic signs. Fever, headache, lethargy, nausea, and vomiting are common. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The key to diagnosis is to consider this rare condition, then to perform a physical examination followed by appropriate imaging. MRI usually provides more information than computed tomography (CT). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Successful treatment of an IEA requires a combination of a drainage procedure and antibiotic therapy. Neurosurgical drainage is usually required, via burr holes or a craniotomy. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Empiric antibiotic therapy should be chosen based upon the probable origin of the infection. If contiguous infection of the paranasal sinuses, ear, or mastoid is the source, a regimen that is active against streptococci, Haemophilus species, and anaerobes should be chosen. The regimens listed above for treatment of SEA when the etiology is unknown are also appropriate for IEA. More specific antibiotic therapy should be given after the results of stains and cultures indicate the organism(s). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/1\">",
"      Danner RL, Hartman BJ. Update on spinal epidural abscess: 35 cases and review of the literature. Rev Infect Dis 1987; 9:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/2\">",
"      Nussbaum ES, Rigamonti D, Standiford H, et al. Spinal epidural abscess: a report of 40 cases and review. Surg Neurol 1992; 38:225.",
"     </a>",
"    </li>",
"    <li>",
"     Gellin BG, Weingarten K, Gamache FW Jr, et al. Epidural Abscess. In: Infections of the Central Nervous System, 2nd Ed, Scheld WM, Whitley RJ, Durack DT (Eds), Lippincott-Raven Publishers, Philadelphia 1997. p.507.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/4\">",
"      Pradilla G, Ardila GP, Hsu W, Rigamonti D. Epidural abscesses of the CNS. Lancet Neurol 2009; 8:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/5\">",
"      Darouiche RO, Hamill RJ, Greenberg SB, et al. Bacterial spinal epidural abscess. Review of 43 cases and literature survey. Medicine (Baltimore) 1992; 71:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/6\">",
"      Akalan N, Ozgen T. Infection as a cause of spinal cord compression: a review of 36 spinal epidural abscess cases. Acta Neurochir (Wien) 2000; 142:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/7\">",
"      Kapeller P, Fazekas F, Krametter D, et al. Pyogenic infectious spondylitis: clinical, laboratory and MRI features. Eur Neurol 1997; 38:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/8\">",
"      Torda AJ, Gottlieb T, Bradbury R. Pyogenic vertebral osteomyelitis: analysis of 20 cases and review. Clin Infect Dis 1995; 20:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/9\">",
"      S&oslash;rensen P. Spinal epidural abscesses: conservative treatment for selected subgroups of patients. Br J Neurosurg 2003; 17:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/10\">",
"      Ptaszynski AE, Hooten WM, Huntoon MA. The incidence of spontaneous epidural abscess in Olmsted County from 1990 through 2000: a rare cause of spinal pain. Pain Med 2007; 8:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/11\">",
"      Cook TM, Counsell D, Wildsmith JA, Royal College of Anaesthetists Third National Audit Project. Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth 2009; 102:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/12\">",
"      Sethna NF, Clendenin D, Athiraman U, et al. Incidence of epidural catheter-associated infections after continuous epidural analgesia in children. Anesthesiology 2010; 113:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/13\">",
"      P&ouml;pping DM, Zahn PK, Van Aken HK, et al. Effectiveness and safety of postoperative pain management: a survey of 18 925 consecutive patients between 1998 and 2006 (2nd revision): a database analysis of prospectively raised data. Br J Anaesth 2008; 101:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/14\">",
"      Reynolds F. Neurological infections after neuraxial anesthesia. Anesthesiol Clin 2008; 26:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/15\">",
"      Gosavi C, Bland D, Poddar R, Horst C. Epidural abscess complicating insertion of epidural catheters. Br J Anaesth 2004; 92:294; author reply 294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/16\">",
"      Scott DB, Hibbard BM. Serious non-fatal complications associated with extradural block in obstetric practice. Br J Anaesth 1990; 64:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/17\">",
"      Gaul C, Neund&ouml;rfer B, Winterholler M. Iatrogenic (para-) spinal abscesses and meningitis following injection therapy for low back pain. Pain 2005; 116:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/18\">",
"      Darouiche RO. Spinal epidural abscess. N Engl J Med 2006; 355:2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/19\">",
"      Sendi P, Bregenzer T, Zimmerli W. Spinal epidural abscess in clinical practice. QJM 2008; 101:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/20\">",
"      Rigamonti D, Liem L, Wolf AL, et al. Epidural abscess in the cervical spine. Mt Sinai J Med 1994; 61:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/21\">",
"      Griffiths DL. Tuberculosis of the spine: a review. Adv Tuberc Res 1980; 20:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/22\">",
"      Chen WC, Wang JL, Wang JT, et al. Spinal epidural abscess due to Staphylococcus aureus: clinical manifestations and outcomes. J Microbiol Immunol Infect 2008; 41:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/23\">",
"      Holt HM, Andersen SS, Andersen O, et al. Infections following epidural catheterization. J Hosp Infect 1995; 30:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/24\">",
"      Phillips JM, Stedeford JC, Hartsilver E, Roberts C. Epidural abscess complicating insertion of epidural catheters. Br J Anaesth 2002; 89:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/25\">",
"      Davis DP, Wold RM, Patel RJ, et al. The clinical presentation and impact of diagnostic delays on emergency department patients with spinal epidural abscess. J Emerg Med 2004; 26:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/26\">",
"      Mooney RP, Hockberger RS. Spinal epidural abscess: a rapidly progressive disease. Ann Emerg Med 1987; 16:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/27\">",
"      Liem LK, Rigamonti D, Wolf AL, et al. Thoracic epidural abscess. J Spinal Disord 1994; 7:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/28\">",
"      Curry WT Jr, Hoh BL, Amin-Hanjani S, Eskandar EN. Spinal epidural abscess: clinical presentation, management, and outcome. Surg Neurol 2005; 63:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/29\">",
"      Davis DP, Salazar A, Chan TC, Vilke GM. Prospective evaluation of a clinical decision guideline to diagnose spinal epidural abscess in patients who present to the emergency department with spine pain. J Neurosurg Spine 2011; 14:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/30\">",
"      Reihsaus E, Waldbaur H, Seeling W. Spinal epidural abscess: a meta-analysis of 915 patients. Neurosurg Rev 2000; 23:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/31\">",
"      Wong D, Raymond NJ. Spinal epidural abscess. N Z Med J 1998; 111:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/32\">",
"      Moseley IF, Kendall BE. Radiology of intracranial empyemas, with special reference to computed tomography. Neuroradiology 1984; 26:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/33\">",
"      Wheeler D, Keiser P, Rigamonti D, Keay S. Medical management of spinal epidural abscesses: case report and review. Clin Infect Dis 1992; 15:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/34\">",
"      Siddiq F, Chowfin A, Tight R, et al. Medical vs surgical management of spinal epidural abscess. Arch Intern Med 2004; 164:2409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/35\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/36\">",
"      Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/37\">",
"      Pfausler B, Spiss H, Beer R, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 2003; 98:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/38\">",
"      Jorgenson L, Reiter PD, Freeman JE, et al. Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices. Pediatr Neurosurg 2007; 43:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/39\">",
"      Wang Q, Shi Z, Wang J, et al. Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients. Surg Neurol 2008; 69:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/40\">",
"      Nau R, Prange HW, Menck S, et al. Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges. J Antimicrob Chemother 1992; 29:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/41\">",
"      Perlroth J, Kuo M, Tan J, et al. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med 2008; 168:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/42\">",
"      von Specht M, Gardella N, Tagliaferri P, et al. Methicillin-resistant Staphylococcus aureus in community-acquired meningitis. Eur J Clin Microbiol Infect Dis 2006; 25:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/43\">",
"      Pintado V, Meseguer MA, Fort&uacute;n J, et al. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis 2002; 21:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/44\">",
"      Gallagher RM, Pizer B, Ellison JA, Riordan FA. Glycopeptide insensitive Staphylococcus aureus subdural empyema treated with linezolid and rifampicin. J Infect 2008; 57:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/45\">",
"      Kessler AT, Kourtis AP. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid. Infection 2007; 35:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/46\">",
"      Naesens R, Ronsyn M, Druw&eacute; P, et al. Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus. J Med Microbiol 2009; 58:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/47\">",
"      Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007; 41:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/48\">",
"      Levitz RE, Quintiliani R. Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann Intern Med 1984; 100:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/49\">",
"      Vartzelis G, Theodoridou M, Daikos GL, et al. Brain abscesses complicating Staphylococcus aureus sepsis in a premature infant. Infection 2005; 33:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/50\">",
"      Lee DH, Palermo B, Chowdhury M. Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin. Clin Infect Dis 2008; 47:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/51\">",
"      Wallace MR, Sander AW, Licitra C, et al. Methicillin-resistant Staphylococcus aureus meningitis successfully treated with daptomycin. Infect Dis Clin Pract 2009; 17:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/52\">",
"      Khanna RK, Malik GM, Rock JP, Rosenblum ML. Spinal epidural abscess: evaluation of factors influencing outcome. Neurosurgery 1996; 39:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/53\">",
"      Baker AS, Ojemann RG, Swartz MN, Richardson EP Jr. Spinal epidural abscess. N Engl J Med 1975; 293:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/54\">",
"      Koo DW, Townson AF, Dvorak MF, Fisher CG. Spinal epidural abscess: a 5-year case-controlled review of neurologic outcomes after rehabilitation. Arch Phys Med Rehabil 2009; 90:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17033/abstract/55\">",
"      Heran NS, Steinbok P, Cochrane DD. Conservative neurosurgical management of intracranial epidural abscesses in children. Neurosurgery 2003; 53:893.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1292 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-3399DFF423-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17033=[""].join("\n");
var outline_f16_40_17033=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H559982872\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SPINAL EPIDURAL ABSCESS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Microbiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Portals of entry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Conservative versus surgical therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Antimicrobial therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H194640138\">",
"      Empiric therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H194640119\">",
"      Subsequent treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H194640152\">",
"      - MRSA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H640150706\">",
"      Duration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      INTRACRANIAL EPIDURAL ABSCESS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pathogenesis and pathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Microbiology and portals of entry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H559982872\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258182987\">",
"      Spinal epidural abscess",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258183069\">",
"      Intracranial epidural abscesses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/1292\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1292|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?34/0/34817\" title=\"diagnostic image 1\">",
"      Spinal epidural abscess MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/46/5856\" title=\"diagnostic image 2\">",
"      Intracranial epidural abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1292|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/14/16612\" title=\"figure 1\">",
"      Vertebral body - transverse section",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/1292|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/51/39739\" title=\"table 1\">",
"      Sources for epidural abscess",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=related_link\">",
"      Approach to the diagnosis and evaluation of low back pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/38/31335?source=related_link\">",
"      Epidemiology of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=related_link\">",
"      Initial therapy and prognosis of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/54/18280?source=related_link\">",
"      Neurologic complications of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/41/38549?source=related_link\">",
"      Pathogenesis and pathophysiology of bacterial meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38104?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=related_link\">",
"      Skeletal tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32438?source=related_link\">",
"      Treatment and prognosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=related_link\">",
"      Treatment of bacterial meningitis caused by specific pathogens in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/28/22985?source=related_link\">",
"      Vertebral osteomyelitis and discitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_40_17034="Pulmonary outcomes of bronchopulmonary dysplasia";
var content_f16_40_17034=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pulmonary outcomes of bronchopulmonary dysplasia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17034/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17034/contributors\">",
"     Leslie L Harris, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17034/contributors\">",
"     James M Adams, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17034/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17034/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17034/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/40/17034/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/40/17034/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/40/17034/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite important advances in perinatal care and a steady decline in mortality rates among very low birth weight (VLBW) infants (&lt;1500 grams) during the past two decades, bronchopulmonary dysplasia (BPD) remains a major complication of neonatal intensive care unit management and a significant cause of long term morbidity.",
"   </p>",
"   <p>",
"    Knowledge of long-term effects of BPD has advanced significantly in recent years. These advances are supported by the development of standardized, physiology-based diagnostic criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/1\">",
"     1",
"    </a>",
"    ] and information about the outcomes of the growing adult populations of surviving premature infants.",
"   </p>",
"   <p>",
"    Although the effects in adults are not yet fully known, it is clear that early lung injury in infancy can have lifelong consequences [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Many patients require multifaceted and multidisciplinary management well beyond the first year of life. Individuals born with very low birth weight have a substantially increased risk of hospitalization for respiratory disease as adults [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/3\">",
"     3",
"    </a>",
"    ]; the risk and character of the respiratory disease may change as cohorts of infants treated with surfactant and other modern management techniques reach adulthood.",
"   </p>",
"   <p>",
"    The long-term pulmonary outcomes of BPD are reviewed here. Long-term outcomes and management of nonpulmonary problems associated with BPD are addressed in a separate topic review. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25398?source=see_link\">",
"     \"Outcome of infants with bronchopulmonary dysplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=see_link\">",
"     \"Care of the neonatal intensive care unit graduate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23912?source=see_link\">",
"     \"Growth management in preterm infants\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The pathogenesis, clinical features, management, and potential strategies to prevent BPD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18793?source=see_link\">",
"     \"Pathogenesis and clinical features of bronchopulmonary dysplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15753?source=see_link\">",
"     \"Management of bronchopulmonary dysplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27880?source=see_link\">",
"     \"Prevention of bronchopulmonary dysplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease of infancy (CLDI) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/4\">",
"     4",
"    </a>",
"    ]. Increasing rates of survival among the smallest infants due to changes in antenatal and postnatal respiratory management, including antenatal steroids and surfactant replacement, contribute to an overall increase in the incidence of BPD, even as other advances in the care of premature infants reduce the risk or severity of BPD in survivors and alter the underlying pathophysiology [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18793?source=see_link&amp;anchor=H6#H6\">",
"     \"Pathogenesis and clinical features of bronchopulmonary dysplasia\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathophysiology of bronchopulmonary dysplasia (BPD) is influenced by a combination of immaturity of the lung, exposures from therapeutic interventions, and heritable factors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. These factors result in one of two pathophysiologic processes, or a mixture of these: (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18793?source=see_link&amp;anchor=H7#H7\">",
"     \"Pathogenesis and clinical features of bronchopulmonary dysplasia\", section on 'Pathology'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Airway injury, inflammation, and alveolar septal fibrosis. These changes are usually associated with oxygen toxicity, barotrauma and infection, and are most prominent in infants with severe BPD who were born before the advent of modern management techniques. This type of pathophysiology is sometimes termed \"classic\" or \"old\" BPD, although occasionally infants in the post-surfactant era still acquire this form of the disease.",
"     </li>",
"     <li>",
"      Disruption of lung development, with decreased septation and alveolar hypoplasia leading to fewer and larger alveoli and dysmorphic pulmonary vasculature [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. These changes are most prominent in infants born after the advent of antepartum glucocorticoid use and surfactant treatment. As compared with infants with classic BPD, many of these infants were exposed to less traumatic ventilator support and lower levels of supplemental oxygen, but they are often of lower birth weight. Some of these infants have little or no respiratory distress after birth, but become chronically dependent on supplemental oxygen. Because of these distinctions from classic BPD, this type of pathophysiology is sometimes termed \"new\" BPD [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In late infancy and childhood, further changes may occur:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lung growth can improve pulmonary function, particularly in infants with mild BPD.",
"     </li>",
"     <li>",
"      Early injury can impair airway growth and so can cause deterioration of airway function and limitation of airflow, particularly in infants with very immature lungs [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/13-16\">",
"       13-16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PULMONARY FUNCTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pulmonary function testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary function testing during infancy is not routinely performed in most centers but can be helpful in tracking changes in pulmonary function, response to bronchodilators and diuretics, and overall severity of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary function testing in older children, adolescents, and adults is more widely available and is useful in following longitudinal changes in pulmonary function. Spirometry (measures of airflow) can be reliably performed in children as young as three years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/18\">",
"     18",
"    </a>",
"    ] and can be measured pre- and post administration of inhaled bronchodilators. Spirometric measures include the forced expiratory volume in one second (FEV1). Measurement of lung volumes includes functional residual capacity (FRC), residual volume (RV) and total lung capacity (TLC) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29112?source=see_link\">",
"     \"Overview of pulmonary function testing in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Late infancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older infants (6 to 12 months) who continue to have persistent respiratory symptoms often will have abnormal pulmonary function studies. However, the type of abnormality varies depending on the method of lung function testing used.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One center made measurements of lung function every three months in a group of infants with bronchopulmonary dysplasia (BPD) over the first year of life [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/19\">",
"       19",
"      </a>",
"      ]. All infants were born between 24 and 31 weeks gestation, were supported with mechanical ventilation, and required supplemental oxygen at 28 days. Mean values of forced expiratory flows at each time point were less than 50 percent of the predicted values. Furthermore, the rate of increase in forced flows over the first year was also lower than predicted. This finding suggests that airway growth not only did not catch up to expected size over the first year, but it also did not even keep pace with the expected increase.",
"     </li>",
"     <li>",
"      A retrospective study examined infants with BPD who were born at 24 to 31 weeks gestation, were oxygen dependent for at least 28 days, and had persistent respiratory symptoms. At ages 10 to 20 months, pulmonary function studies demonstrated decreased flow rates and low FRC, indicating a component of restrictive lung disease [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another series described alterations in tidal mechanics and lung volumes in infants born before 29 weeks gestation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/21\">",
"       21",
"      </a>",
"      ]. 63 percent had a history of BPD (defined by a supplemental oxygen requirement at 36 weeks postmenstrual age), and half of whom had persistent wheezing [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/21\">",
"       21",
"      </a>",
"      ]. Pulmonary function tests performed at one year of age demonstrated evidence of gas-trapping. These findings suggest small airway dysfunction. Since alveolar wall attachments tether small airways open, this finding could reflect either small airway damage, or the effect of reduced alveolar number, consistent with abnormal lung development, as is typical of \"new\" BPD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Infants with BPD may require supplementary oxygen after hospital discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17\">",
"     17",
"    </a>",
"    ]. In a series of infants with gestational ages 22 to 31 weeks treated in England in the late 1990s, 37 percent were discharged to home on oxygen. More than half of infants with BPD require hospital admission during the first two years of life, usually for acute respiratory infections [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15753?source=see_link&amp;anchor=H4#H4\">",
"     \"Management of bronchopulmonary dysplasia\", section on 'Oxygen'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Childhood",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical symptoms often improve gradually with advancing age during childhood (ages 1 to 12 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/4\">",
"     4",
"    </a>",
"    ]. However, tests of pulmonary function may or may not improve, depending on the severity of the underlying disease:",
"   </p>",
"   <p>",
"    Individuals with severe BPD have abnormal pulmonary function tests for many years. As an example, children with severe BPD studied during early childhood (&lt;3 years of age) have decreased FEV1 as well as increased FRC, RV and",
"    <span class=\"nowrap\">",
"     RV/TLC",
"    </span>",
"    as compared with healthy children [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/23\">",
"     23",
"    </a>",
"    ]. These findings are consistent with persistent airflow obstruction and gas trapping. In a similar group of patients, sequential measurements during the first two to three years following hospital discharge demonstrated normalization of FRC",
"    <span class=\"nowrap\">",
"     (mL/kg)",
"    </span>",
"    from initial low levels to more normal levels, and persistent limitations measured at FRC [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/24\">",
"     24",
"    </a>",
"    ]. Approximately one third of these patients responded to bronchodilators. In another study, forced expiratory flow at two years of age was closely related to forced expiratory flow at eight years, suggesting little remodeling of the lung [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In many patients, especially those with mild disease, some pulmonary function tests gradually improve over time, possibly in conjunction with new alveolar development [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/14,25\">",
"     14,25",
"    </a>",
"    ]. This was demonstrated in a study of 39 preterm infants (mean gestational age 29.8 weeks) with classic BPD who had serial measurements of tidal mechanics and lung volume from 1 to 36 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/25\">",
"     25",
"    </a>",
"    ]. Although minute ventilation and respiratory effort remained increased throughout the study, FRC gradually decreased during the first six months, then became normal. Lung compliance improved from 50 percent of normal at one month of age to 80 percent of normal at 36 months. Specific pulmonary conductance (the reciprocal of resistance, normalized to FRC) was 50 percent of normal at one month, changed little until six months, and improved to 85 percent of normal at 36 months. Airway growth relative to lung volume remained slow during the first year of life but subsequently increased, leading to improved conductance.",
"   </p>",
"   <p>",
"    In addition to the severity of the underlying BPD, birth weight and environmental factors, including tobacco smoke exposure and environmental allergens, affect the respiratory outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Long-term changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term changes in pulmonary function have been described for individuals with the classic form of BPD, and may persist into adolescence and adulthood. Much less is known regarding the long-term outcome of infants managed with modern neonatal intensive care unit (NICU) strategies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Classic BPD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with classic BPD may have abnormal pulmonary function tests throughout childhood and adolescence [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/28-31\">",
"     28-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, in a study of 147 adolescents born weighing less than 1500 g in the period 1977 to 1982, pulmonary function testing at a mean of 18.9 years demonstrated clinically significant reduction in airflow and deterioration in pulmonary function since the previous evaluation at eight years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/32\">",
"     32",
"    </a>",
"    ]. Similarly, long-term studies suggest that children ages 6 to 15 years with BPD demonstrate persistent airway obstruction, airway hyperreactivity, and hyperinflation of the lungs [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/28-31,33-51\">",
"     28-31,33-51",
"    </a>",
"    ]. Both vital capacity and FEV1 are reduced as compared with control subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17\">",
"     17",
"    </a>",
"    ]. These abnormalities may persist into adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/2,52\">",
"     2,52",
"    </a>",
"    ]. The duration of oxygen dependence in the neonatal period may be a good predictor of respiratory morbidity during early childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/53\">",
"     53",
"    </a>",
"    ] and possibly of long-term pulmonary outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Environmental factors may contribute to the pulmonary function abnormalities. Among individuals with extremely low birth weights (&lt;1000 g), those who smoked during adolescence were more likely to experience a decline in pulmonary function during adolescence as compared with nonsmokers [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     New BPD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term outcomes discussed above describe changes in pulmonary function among individuals who developed BPD during the 1980s, before the advent of surfactant. Because of advances in NICU respiratory management, more recent cohorts of infants tend to have milder BPD. However, the recent cohorts are also more likely to have extremely low birth weight, and they may experience unique complications because of their immature lungs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    because of different treatment exposures. Thus, the overall impact of newer interventions on long-term pulmonary function is unknown. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Pathophysiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Only a few studies have compared outcomes of early versus late cohorts. In one study, long-term pulmonary function was evaluated in two groups of subjects who were treated in a NICU in Norway [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/57\">",
"     57",
"    </a>",
"    ]. The first group was born between 1982 and 1985, prior to the use of surfactant. The second group was born between 1991 and 1992, when surfactant was used as rescue therapy for respiratory distress syndrome. The mean FEV1 was similar between the two groups of children with BPD (81.9 and 80.8 percent predicted) and was lower than the control groups born during the two time periods (98.9 and 98.2 percent predicted). Pulmonary function might also be influenced by other differences between the groups, including the lower birth weight and younger age of follow up testing in the second group (10.6 versus 17.7 years).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ASTHMA-LIKE SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent wheezing episodes are common in children and adolescents with a history of BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/2,27,32,58,59\">",
"     2,27,32,58,59",
"    </a>",
"    ]. Adolescents also experience reduced exercise tolerance, impaired ventilatory adaptation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/30,49,60\">",
"     30,49,60",
"    </a>",
"    ], and reduced gas transfer during physical activity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/30,47,61\">",
"     30,47,61",
"    </a>",
"    ]. Additionally, 40 to 50 percent of children with a history of BPD demonstrate significant airway hyperresponsiveness to exercise, histamine or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/32/10756?source=see_link\">",
"     methacholine",
"    </a>",
"    , or a significant response to bronchodilator administration [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/62\">",
"     62",
"    </a>",
"    ]. This prevalence of airway hyperreactivity, however, is not different from that of children born prematurely without BPD. Unlike children with asthma, those with BPD who have demonstrable airway hyperreactivity do not have elevated levels of exhaled nitric oxide (a marker for eosinophil-driven inflammation) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/15,63\">",
"     15,63",
"    </a>",
"    ] or an increased incidence of atopy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although children with BPD and children with asthma have similar symptoms, the underlying pathophysiology of these two diseases is different. The lung of the older child and adult recovered from BPD demonstrates airway wall thickening similar to individuals with asthma. However, in addition there are morphologic changes noted on CT scans of the chest, including linear and triangular opacities, mosaic perfusion, and air-trapping more akin to bronchiolitis obliterans [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/64\">",
"     64",
"    </a>",
"    ], which are compatible with a diagnosis of fixed peripheral airway narrowing.",
"   </p>",
"   <p>",
"    Children with asthma-like symptoms due to BPD may respond to inhaled corticosteroids, but the effect is less consistent than in children with asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17,65-67\">",
"     17,65-67",
"    </a>",
"    ]. In some infants with central airway disease (tracheobronchomalacia), bronchodilators can exacerbate wheezing [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17,68\">",
"     17,68",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Acquired tracheobronchomalacia'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PULMONARY ARTERY HYPERTENSION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Pathogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary artery hypertension (PAH) and the resultant right heart failure (cor pulmonale) associated with severe bronchopulmonary dysplasia (BPD) is caused by both structural and functional changes within the lung. Gentler ventilatory practices and avoidance of oxygen toxicity may decrease the risk or severity of PAH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/69,70\">",
"     69,70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PAH in infants with BPD results from a combination of factors, including an absolute reduction in the size and complexity of the pulmonary vascular bed, increased resting tone of pulmonary artery smooth muscle, and increased reactivity of the arteries to a variety of stimuli. While current therapies can reduce pulmonary artery reactivity and promote remodeling that reduces resting pulmonary artery tone, the long-term effects of a reduced pulmonary capillary bed on the course of pulmonary hypertension in BPD patients are unclear.",
"     </li>",
"     <li>",
"      The effects of oxygen toxicity and ventilator-induced barotrauma and volutrauma on the immature lung can also interfere with alveolar development, reducing the number of alveoli and intraacinar arteries. The molecular mechanisms of these effects include impaired production of nitric oxide and vascular endothelial growth factor (VEGF), and increased expression of endoglin, which is involved in angiogenesis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/71-73\">",
"       71-73",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Alternatively, chronic or intermittent alveolar hypoxia and acidosis cause acute vasoconstriction and produce further structural change within the affected pulmonary arteries, including endothelial cell injury, intimal proliferation, medial hypertrophy, and extension of muscle into the arterial wall.",
"     </li>",
"     <li>",
"      Left ventricular diastolic dysfunction (which may be caused by systemic hypertension and steroid use) can contribute to the PAH and pulmonary edema [",
"      <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/74\">",
"       74",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Natural history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of PAH in infants with BPD is an important mortality risk factor. However, medial hypertrophy improves with age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/75\">",
"     75",
"    </a>",
"    ]. Therefore, infants surviving the initial stages of PAH often experience improvement.",
"   </p>",
"   <p>",
"    As an example, in a study of patients with BPD and PAH treated during the surfactant era, 16 of 42 died within 6 months of diagnosis (median postnatal age at diagnosis and death: 4.8 and 10.9 months, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/76\">",
"     76",
"    </a>",
"    ]. Twenty-four of 26 survivors subsequently had improvement in their PAH (median follow up 9.8 months), but only five had normal right ventricular pressures.",
"   </p>",
"   <p>",
"    Another study used serial Doppler echocardiography to investigate changes in pulmonary artery pressure (PAP) in preterm infants with BPD up to one year of age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/77\">",
"     77",
"    </a>",
"    ]. PAP was measured by the ratio of acceleration time to right ventricular ejection time",
"    <span class=\"nowrap\">",
"     (AT/RVET).",
"    </span>",
"    PAP gradually fell with increasing age, but remained elevated as compared with a control group of healthy infants, as reflected by a lower median",
"    <span class=\"nowrap\">",
"     AT/RVET",
"    </span>",
"    (0.31 versus 0.37).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac catheterization is the gold standard in detecting and determining the severity of PAH, but echocardiography is a reliable and safer modality to screen and monitor PAH in infants with BPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Doppler echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doppler echocardiography is the most commonly performed procedure to assess pulmonary artery pressure in infants with BPD. It should be performed before hospital discharge in infants who continue to have a need for supplemental oxygen. If significant pulmonary hypertension is present, serial echocardiography every two to three months is recommended until resolution is assured [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary artery pressure and the response to oxygen are estimated using tricuspid regurgitant jet velocity (TRJV)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary systolic time intervals [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/79\">",
"     79",
"    </a>",
"    ]. Right ventricular structural or functional abnormalities are sometimes used as indirect indicators of PAH, including septal flattening, right atrial enlargement, and right ventricular hypertrophy, dilation, and function. In the previously mentioned case series of infants with PAH and BPD, severe PAH was defined as systemic or suprasystemic right ventricular pressure as estimated by echocardiography [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are some limitations of Doppler echocardiography in comparison to the more invasive cardiac catheterization. This was illustrated in a retrospective study of 25 children with PAH (including 17 patients with BPD) who underwent both echocardiography and cardiac catheterization [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/80\">",
"     80",
"    </a>",
"    ]. TRJV could be measured in only 61 percent of infants. When this parameter could be measured, the presence or absence of PAH was correctly identified in 80 percent of studies, although echocardiography performed poorly in discriminating between mild and severe PAH. By contrast, echocardiographic evidence of abnormalities in right ventricular structure or function was a relatively poor predictor of PAH, particularly in studies in which TRJV could not be measured.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Cardiac catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac catheterization is the gold standard for detecting PAH and for determining its severity. However, it is an invasive procedure with a significant complication rate. It can provide useful information in infants with severe PAH by evaluating cardiac anatomy, reactivity of the pulmonary vascular bed to oxygen or vasodilators, and assessing for development of large systemic-pulmonary collaterals which can contribute to the development of PAH by increasing pulmonary blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17,81\">",
"     17,81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrocardiograms (ECGs) have been used to assess PAH in infants with mild BPD who are improving. However, ECGs can be normal or have minimal abnormalities in some patients with PAH and severe right ventricular dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/78\">",
"     78",
"    </a>",
"    ]. We do not feel ECGs are adequate for monitoring cardiopulmonary status and assessing pulmonary artery pressure in infants with moderate or severe BPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     CENTRAL AND UPPER AIRWAY DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The central airways span the glottis to the lobar or segmental bronchi. Acquired damage to the airways in infancy may persist into early childhood and beyond. Infants and young children with bronchopulmonary dysplasia (BPD) are at risk of central airway collapse or obstruction, which can lead to \"BPD spells\" or cyanotic or life-threatening episodes, chronic wheezing unresponsive to bronchodilator therapy, recurrent atelectasis, lobar emphysema, or failure to wean from mechanical ventilation or to tolerate tracheal extubation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Acquired tracheobronchomalacia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheobronchomalacia is characterized by abnormally compliant, collapsible central airways. In infants with BPD, it is thought to result from barotrauma, chronic or recurrent infection, and endotracheal intubation. Tracheobronchomalacia tends to improve with age, as the tracheal cartilage matures and becomes less compliant [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/82-85\">",
"     82-85",
"    </a>",
"    ]. Nonetheless, it has been noted in patients with BPD as old as 35 months [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/86-91\">",
"     86-91",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=see_link&amp;anchor=H11#H11\">",
"     \"Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula\", section on 'Tracheomalacia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18088?source=see_link\">",
"     \"Tracheomalacia and tracheobronchomalacia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms of tracheobronchomalacia include \"BPD spells\" or reflex apnea (episodes of cyanosis that may be life-threatening) during infancy. Affected infants and children may also have chronic wheezing that does not improve or worsens with bronchodilator therapy or increased work of breathing [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17\">",
"     17",
"    </a>",
"    ]. The symptoms typically increase with crying or exertion.",
"   </p>",
"   <p>",
"    In one study, tracheomalacia was found in 45 percent of infants with BPD undergoing bronchoscopy, and bronchomalacia in 34 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/92\">",
"     92",
"    </a>",
"    ]. However, this and other studies describe a population selected for symptoms, so the actual incidence of tracheobronchomalacia in infants or older children with BPD is unknown.",
"   </p>",
"   <p>",
"    Prolonged pressure deformation in the immature airway can also increase the size of the airway, causing tracheomegaly. Tracheomegaly has been described in extremely low birth weight infants (&lt;1000 g) after mechanical ventilatory support [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Glottic and subglottic damage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury to the glottis and surrounding structures has been reported after endotracheal intubation in newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/94-103\">",
"     94-103",
"    </a>",
"    ]. Epithelial damage after endotracheal intubation is a common occurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/98,100\">",
"     98,100",
"    </a>",
"    ], but most superficial lesions resolve without further sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/95,96,102\">",
"     95,96,102",
"    </a>",
"    ]. Acquired subglottic stenosis and laryngeal injury is seen more often in infants who have been intubated for a week or longer and who required three or more intubations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/94,95,102\">",
"     94,95,102",
"    </a>",
"    ]. The use of inappropriately large endotracheal tubes has also been implicated [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/94,102,103\">",
"     94,102,103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postextubation stridor is the most common sign of moderate to severe subglottic stenosis or laryngeal injury [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/94,102\">",
"     94,102",
"    </a>",
"    ]. The child may have chronic symptoms or exhibit symptoms only during acute upper respiratory tract infections. Children with BPD and stridor should be evaluated endoscopically to determine the level and cause of airway obstruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/61/21464?source=see_link\">",
"     \"Assessment of stridor in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Tracheal and bronchial stenosis and granuloma formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acquired tracheal or bronchial stenosis or granuloma formation has been reported in a subset of infants with BPD as old as 17 months [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/86,87,92,104-108\">",
"     86,87,92,104-108",
"    </a>",
"    ]. Stenosis and granulation formation is probably not the result of lung disease itself but rather the result of trauma from artificial airways and suctioning techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/109-112\">",
"     109-112",
"    </a>",
"    ]. These injuries can cause long-term pulmonary problems, including acquired lobar emphysema or persistent lobar atelectasis, depending on the degree of luminal obstruction. Acquired lobar atelectasis occurs when a partial obstruction allows air to enter the lung distal to the lesion on inspiration but prevents egress of air on exhalation; lobar atelectasis can develop if the obstruction is complete on both phases of respiration. These complications are seen much less frequently, since the practice of \"deep suctioning\" (passing a suction catheter until resistance is felt, then applying suction to the airway) has been abandoned by most neonatal units.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SLEEP HYPOXEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with a history of bronchopulmonary dysplasia (BPD) are more likely to experience hypoxemic episodes during sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/113-117\">",
"     113-117",
"    </a>",
"    ], and these episodes may be clinically silent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/114\">",
"     114",
"    </a>",
"    ]. Episodes of desaturation are more common during REM sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/114\">",
"     114",
"    </a>",
"    ], when intercostal and upper airway muscle tone is reduced, leading to a reduction in both functional residual capacity and upper airway resistance. The former leads to further closure of diseased and narrowed airways as FRC falls below closing volume, thereby producing an increase in low",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    regions. Arousal due to hypoxemia appears to be age-dependent but may lead to decreased sleep time during REM sleep in these infants [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/118,119\">",
"     118,119",
"    </a>",
"    ]. Other contributing factors that may play a role include inadequate autonomic response mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/120\">",
"     120",
"    </a>",
"    ] and hypoxemia-induced airway narrowing [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/121\">",
"     121",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypoxemic episodes during sleep can also affect older children. In one study of patients aged three to five years with severe BPD, multiple prolonged episodes of desaturation occurred during sleep, especially during REM sleep, despite adequate oxygen saturation when awake [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/122\">",
"     122",
"    </a>",
"    ]. In another study of 17 children (mean age nine years), there were similar findings [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/123\">",
"     123",
"    </a>",
"    ]. Increased thoraco-abdominal asynchrony during sleep has also been found in children with severe BPD (age range 19 to 46 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/124\">",
"     124",
"    </a>",
"    ]. Sleep related hypoxemia may also lead to decreased biventricular function [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/125\">",
"     125",
"    </a>",
"    ] and impaired autonomic heart rate control in these children [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/126\">",
"     126",
"    </a>",
"    ]. The incidence of sleep-disordered breathing is greater in school-age children with a history of prematurity, but not necessarily of BPD, compared with those born at term [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/127\">",
"     127",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Sleep hypoxemia is associated with growth delay in infants with BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/128\">",
"     128",
"    </a>",
"    ]. The clinical consequences of sleep hypoxemia in older children with BPD are not established. Obstructive sleep apnea in children with or without BPD can cause sleep fragmentation with multiple nighttime arousals, and lead to neuropsychological morbidity, including decreased school performance. Similarly, there is an increased risk of pulmonary hypertension in rats and adult patients with hypoxemia during sleep, but there are no data addressing chronic sleep hypoxemia and risk of pulmonary hypertension in the pediatric population at this time.",
"   </p>",
"   <p>",
"    The management of infants with evidence of sleep hypoxemia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15753?source=see_link&amp;anchor=H18#H18\">",
"     \"Management of bronchopulmonary dysplasia\", section on 'Oxygenation'",
"    </a>",
"    .) A polysomnography study is indicated in infants or children with BPD and symptoms of upper airway obstruction during sleep (eg, snoring). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=see_link\">",
"     \"Evaluation of suspected obstructive sleep apnea in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     RESPIRATORY INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory infections, including respiratory syncytial virus (RSV), are more severe in children with bronchopulmonary dysplasia (BPD) and contribute to high rates of rehospitalization, especially within the first year. These infections may be life-threatening, and those with severe lung-function abnormalities are more susceptible [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/129\">",
"     129",
"    </a>",
"    ]. This is especially true for those infants who still require supplemental oxygen at the time of infection [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/130\">",
"     130",
"    </a>",
"    ]. Furthermore, children with BPD who had been hospitalized with an RSV infection within the first two years of life have increased health care costs and worse lung function at school age than those who did not experience an RSV-related hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/131\">",
"     131",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For these reasons, infants and children with BPD require additional immunizations, and prophylaxis for RSV is indicated for some infants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=see_link&amp;anchor=H7#H7\">",
"     \"Care of the neonatal intensive care unit graduate\", section on 'Immunization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     IMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Oxygen therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoxic episodes in infants and children can be linked to, and even worsen, already impaired lung mechanics, elevated airway resistance, and obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/114,120,121\">",
"     114,120,121",
"    </a>",
"    ]. Oxygen supplementation is known to benefit these infants by decreasing airway resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/132\">",
"     132",
"    </a>",
"    ] and decreasing pulmonary vascular resistance, thus reversing some components of pulmonary artery hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/133-135\">",
"     133-135",
"    </a>",
"    ]. It can also improve central respiratory drive [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/116\">",
"     116",
"    </a>",
"    ], increase sleep duration by increasing REM sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/118\">",
"     118",
"    </a>",
"    ], and increase growth velocity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/128,135,136\">",
"     128,135,136",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infants beyond term and with mature retinal development should receive oxygen supplementation as needed to maintain a target saturation of 93 percent or more, particularly in infants with pulmonary artery hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/17,78\">",
"     17,78",
"    </a>",
"    ]. As the infant's respiratory status improves, the supplemental oxygen should be slowly weaned. Adjustments should be guided by monitoring with pulse oximetry in a variety of states, recognizing that oxygenation often decreases during or after feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/114,137\">",
"     114,137",
"    </a>",
"    ], sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/114,116,117\">",
"     114,116,117",
"    </a>",
"    ], and during intercurrent illnesses. Additionally, sustained growth and stamina for therapies or periods of play must be assured while supplemental oxygen is withdrawn. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Sleep hypoxemia'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15753?source=see_link&amp;anchor=H18#H18\">",
"     \"Management of bronchopulmonary dysplasia\", section on 'Oxygenation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Tracheostomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with obstructive central and upper airway disease may require a chronic tracheostomy for months or even years after hospital discharge. Such infants require coordinated care involving their primary physician, pediatric otolaryngologist, pulmonologist, and provider of home care services. A speech pathologist is often helpful in the evaluation and management of swallowing and speech development. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Central and upper airway disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Before these patients can transition to home care, the family must be trained in tracheostomy maintenance and emergency procedures. Two caregivers should be identified and trained in routine suctioning, cleaning and changing the tracheostomy, general respiratory assessment, and cardiopulmonary resuscitation of a patient with a tracheostomy. The caregivers must demonstrate proficiency in routine and emergency skills before the child is discharged from the health care facility to home. Families should have a back-up tracheostomy tube that is one size smaller than the one in use; this will be easier to insert in case of accidental decannulation.",
"   </p>",
"   <p>",
"    For any child with a tracheostomy who is at high risk for airway complications and cannot call for help or self-correct a problem, some form of monitoring should be used when not under direct visual monitoring. Pulse oximetry is often chosen over a cardiorespiratory monitor since hypoxemia or tachycardia will occur before bradycardia from prolonged hypoxemia, and a child with a critically obstructed or displaced tracheostomy tube will make ineffective breathing efforts that will delay the cardiorespiratory monitor from alarming. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Cardiorespiratory monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Because all monitors have limitations, daily skilled nursing care is considered to be a standard of care for a child at home with a tracheostomy; minimum hours of nursing care are not evidence-based, but range between 8",
"    <span class=\"nowrap\">",
"     hour/day",
"    </span>",
"    for children with tracheostomies, and longer (up to 16",
"    <span class=\"nowrap\">",
"     hours/day",
"    </span>",
"    in some US states) for children requiring mechanical ventilation via the tracheostomy. This support allows the child to be visually monitored at least while the parents sleep. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Cardiorespiratory monitoring'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Guidelines on the care of the child with chronic tracheostomy have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?16/40/17034/abstract/138\">",
"     138",
"    </a>",
"    ]. Children with tracheostomies should undergo periodic bronchoscopy every 6 to 12 months to monitor the airway, assess tracheostomy tube size, and evaluate readiness for decannulation. Granulomas often form near the tracheostomy site and require removal; other complications include recurrent tracheitis or bronchitis, and (rarely) hemorrhage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Cardiorespiratory monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine use of cardiorespiratory monitors is not indicated for children with bronchopulmonary dysplasia (BPD) after hospital discharge. However, home monitors may be appropriate for selected infants who are at risk of acute obstructive events due to tracheobronchomalacia or stenosis, or those who require tracheostomies or supplemental oxygen. In this case, it is important to monitor oxygen saturation or a device that can detect obstructive apnea; standard cardiorespiratory monitors do not detect obstructive apnea in the absence of bradycardia. Providers and families should recognize that monitors provide only indirect evidence of airway compromise, and alarms are often delayed. There is no good substitute for close direct observation of the tracheotomized patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/58/21414?source=see_link&amp;anchor=H8#H8\">",
"     \"Use of home cardiorespiratory monitors in infants\", section on 'Other indications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Acute respiratory illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;To reduce risks for asthma and respiratory infections, all families should be counseled to take the following measures:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Frequent handwashing and avoidance of exposing the infant and young child to respiratory infections; administration of standard and supplementary immunizations, and prophylaxis for RSV as indicated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=see_link&amp;anchor=H7#H7\">",
"       \"Care of the neonatal intensive care unit graduate\", section on 'Immunization'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H24\">",
"       'Respiratory infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Strict avoidance of tobacco smoke exposure. Eliminating all smoking within the home is an important goal; intermediate measures to limit a child's exposure are not very effective. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/58/41895?source=see_link\">",
"       \"Control of secondhand smoke exposure\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H4\">",
"       'Pulmonary function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Anticipatory guidance to ensure that adolescents do not begin to smoke, and support for smoking cessation in those who do. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Asthma-like symptoms'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Care setting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children, adolescents, and young adults with BPD may be followed-up in a number of outpatient clinic settings. These include a pediatrician's office or a hospital-based follow-up clinic. In either case, the patient should be referred to a pulmonologist familiar with the care of these often medically fragile patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=see_link\">",
"     \"Care of the neonatal intensive care unit graduate\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Early lung injury in infancy due to bronchopulmonary dysplasia (BPD) can have lifelong consequences, manifested by altered pulmonary function, central and upper airway disease, and in some cases, pulmonary hypertension.",
"     </li>",
"     <li>",
"      In infants who were born before the advent of modern NICU management techniques, BPD is typically characterized by airway injury with inflammation and alveolar septal fibrosis. These changes are usually associated with oxygen toxicity,",
"      <span class=\"nowrap\">",
"       barotrauma/volutrauma,",
"      </span>",
"      and infection. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants born after the advent of antepartum glucocorticoid use and surfactant treatment are more likely to display disruption of lung development, with decreased septation and alveolar hypoplasia leading to fewer and larger alveoli and dysmorphic pulmonary vasculature. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Recurrent wheezing episodes are common in children and adolescents with a history of BPD, but the underlying pathophysiology is somewhat different from asthma. Bronchodilators are effective on only about half of these patients. In infants or children with tracheobronchomalacia, bronchodilators may actually worsen symptoms. There are no data on the use of inhaled steroids to control asthma symptoms in children with a history of BPD. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Asthma-like symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants with severe BPD may develop pulmonary artery hypertension (PAH). Infants who have a need for supplemental oxygen at the time of hospital discharge should be evaluated for PAH using Doppler echocardiography, which should be performed before hospital discharge. If pulmonary hypertension is present, these infants should be followed with serial assessment as outpatients. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Pulmonary artery hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants and young children with BPD are at risk of central airway collapse due to tracheobronchomalacia, which can aggravate underlying thoracic airway disease associated with BPD and produce \"BPD spells\" or cyanotic or life-threatening episodes, chronic wheezing unresponsive to bronchodilator therapy, a propensity for atelectasis, and failure to wean from mechanical ventilation or to tolerate tracheal extubation. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Central and upper airway disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/1\">",
"      Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/2\">",
"      Northway WH Jr, Moss RB, Carlisle KB, et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990; 323:1793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/3\">",
"      Walter EC, Ehlenbach WJ, Hotchkin DL, et al. Low birth weight and respiratory disease in adulthood: a population-based case-control study. Am J Respir Crit Care Med 2009; 180:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/4\">",
"      Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357:1946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/5\">",
"      Manktelow BN, Draper ES, Annamalai S, Field D. Factors affecting the incidence of chronic lung disease of prematurity in 1987, 1992, and 1997. Arch Dis Child Fetal Neonatal Ed 2001; 85:F33.",
"     </a>",
"    </li>",
"    <li>",
"     Northway WH Jr. Bronchopulmonary dysplasia: 30 years later. In: 4th International Conference on Pediatric Pulmonology. Nice, France 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/7\">",
"      Wright K. Death postponement and increased chronic lung disease: the hidden costs of mortality reduction in the post-surfactant era. J Assoc Acad Minor Phys 1999; 10:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/8\">",
"      Bhandari V, Bizzarro MJ, Shetty A, et al. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006; 117:1901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/9\">",
"      Abman SH, Mourani PM, Sontag M. Bronchopulmonary dysplasia: a genetic disease. Pediatrics 2008; 122:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/10\">",
"      Balinotti JE, Chakr VC, Tiller C, et al. Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. Am J Respir Crit Care Med 2010; 181:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/11\">",
"      Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/12\">",
"      Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999; 46:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/13\">",
"      Hofhuis W, Huysman MW, van der Wiel EC, et al. Worsening of V'maxFRC in infants with chronic lung disease in the first year of life: a more favorable outcome after high-frequency oscillation ventilation. Am J Respir Crit Care Med 2002; 166:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/14\">",
"      Baraldi E, Filippone M, Trevisanuto D, et al. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997; 155:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/15\">",
"      Filippone M, Sartor M, Zacchello F, Baraldi E. Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age. Lancet 2003; 361:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/16\">",
"      Tepper RS, Morgan WJ, Cota K, Taussig LM. Expiratory flow limitation in infants with bronchopulmonary dysplasia. J Pediatr 1986; 109:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/17\">",
"      Allen J, Zwerdling R, Ehrenkranz R, et al. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003; 168:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/18\">",
"      Eigen H, Bieler H, Grant D, et al. Spirometric pulmonary function in healthy preschool children. Am J Respir Crit Care Med 2001; 163:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/19\">",
"      Iles R, Edmunds AT. Assessment of pulmonary function in resolving chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 1997; 76:F113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/20\">",
"      Mahut B, De Blic J, Emond S, et al. Chest computed tomography findings in bronchopulmonary dysplasia and correlation with lung function. Arch Dis Child Fetal Neonatal Ed 2007; 92:F459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/21\">",
"      Broughton S, Thomas MR, Marston L, et al. Very prematurely born infants wheezing at follow-up: lung function and risk factors. Arch Dis Child 2007; 92:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/22\">",
"      Greenough A, Alexander J, Burgess S, et al. Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease. Arch Dis Child 2002; 86:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/23\">",
"      Robin B, Kim YJ, Huth J, et al. Pulmonary function in bronchopulmonary dysplasia. Pediatr Pulmonol 2004; 37:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/24\">",
"      Fakhoury KF, Sellers C, Smith EO, et al. Serial measurements of lung function in a cohort of young children with bronchopulmonary dysplasia. Pediatrics 2010; 125:e1441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/25\">",
"      Gerhardt T, Hehre D, Feller R, et al. Serial determination of pulmonary function in infants with chronic lung disease. J Pediatr 1987; 110:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/26\">",
"      Korhonen P, Laitinen J, Hy&ouml;dynmaa E, Tammela O. Respiratory outcome in school-aged, very-low-birth-weight children in the surfactant era. Acta Paediatr 2004; 93:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/27\">",
"      Doyle LW, Victorian Infant Collaborative Study Group. Respiratory function at age 8-9 years in extremely low birthweight/very preterm children born in Victoria in 1991-1992. Pediatr Pulmonol 2006; 41:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/28\">",
"      Giacoia GP, Venkataraman PS, West-Wilson KI, Faulkner MJ. Follow-up of school-age children with bronchopulmonary dysplasia. J Pediatr 1997; 130:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/29\">",
"      Gross SJ, Iannuzzi DM, Kveselis DA, Anbar RD. Effect of preterm birth on pulmonary function at school age: a prospective controlled study. J Pediatr 1998; 133:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/30\">",
"      Jacob SV, Lands LC, Coates AL, et al. Exercise ability in survivors of severe bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997; 155:1925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/31\">",
"      Pelkonen AS, Hakulinen AL, Turpeinen M. Bronchial lability and responsiveness in school children born very preterm. Am J Respir Crit Care Med 1997; 156:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/32\">",
"      Doyle LW, Faber B, Callanan C, et al. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006; 118:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/33\">",
"      Andr&eacute;asson B, Lindroth M, Mortensson W, et al. Lung function eight years after neonatal ventilation. Arch Dis Child 1989; 64:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/34\">",
"      Arad I, Bar-Yishay E, Eyal F, et al. Lung function in infancy and childhood following neonatal intensive care. Pediatr Pulmonol 1987; 3:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/35\">",
"      Bader D, Ramos AD, Lew CD, et al. Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia. J Pediatr 1987; 110:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/36\">",
"      Bertrand JM, Riley SP, Popkin J, Coates AL. The long-term pulmonary sequelae of prematurity: the role of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med 1985; 312:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/37\">",
"      Blayney M, Kerem E, Whyte H, O'Brodovich H. Bronchopulmonary dysplasia: improvement in lung function between 7 and 10 years of age. J Pediatr 1991; 118:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/38\">",
"      Cano A, Payo F. Lung function and airway responsiveness in children and adolescents after hyaline membrane disease: a matched cohort study. Eur Respir J 1997; 10:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/39\">",
"      Doyle LW, Ford GW, Olinsky A, et al. Bronchopulmonary dysplasia and very low birthweight: lung function at 11 years of age. J Paediatr Child Health 1996; 32:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/40\">",
"      Hakulinen AL, Heinonen K, L&auml;nsimies E, Kiekara O. Pulmonary function and respiratory morbidity in school-age children born prematurely and ventilated for neonatal respiratory insufficiency. Pediatr Pulmonol 1990; 8:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/41\">",
"      Hakulinen AL, J&auml;rvenp&auml;&auml; AL, Turpeinen M, Sovij&auml;rvi A. Diffusing capacity of the lung in school-aged children born very preterm, with and without bronchopulmonary dysplasia. Pediatr Pulmonol 1996; 21:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/42\">",
"      Jacob SV, Coates AL, Lands LC, et al. Long-term pulmonary sequelae of severe bronchopulmonary dysplasia. J Pediatr 1998; 133:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/43\">",
"      Kitchen WH, Olinsky A, Doyle LW, et al. Respiratory health and lung function in 8-year-old children of very low birth weight: a cohort study. Pediatrics 1992; 89:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/44\">",
"      Koumbourlis AC, Motoyama EK, Mutich RL, et al. Longitudinal follow-up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease. Pediatr Pulmonol 1996; 21:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/45\">",
"      MacLusky IB, Stringer D, Zarfen J, et al. Cardiorespiratory status in long-term survivors of prematurity, with and without hyaline membrane disease. Pediatr Pulmonol 1986; 2:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/46\">",
"      Mansell AL, Driscoll JM, James LS. Pulmonary follow-up of moderately low birth weight infants with and without respiratory distress syndrome. J Pediatr 1987; 110:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/47\">",
"      Mitchell SH, Teague WG. Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1998; 157:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/48\">",
"      Parat S, Moriette G, Delaperche MF, et al. Long-term pulmonary functional outcome of bronchopulmonary dysplasia and premature birth. Pediatr Pulmonol 1995; 20:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/49\">",
"      Santuz P, Baraldi E, Zaramella P, et al. Factors limiting exercise performance in long-term survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995; 152:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/50\">",
"      Sheller JR. Childhood pulmonary function following hyaline membrane disease. Compr Ther 1990; 16:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/51\">",
"      Smyth JA, Tabachnik E, Duncan WJ, et al. Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics 1981; 68:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/52\">",
"      Gough A, Spence D, Linden M, et al. General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review. Chest 2012; 141:1554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/53\">",
"      Kinali M, Greenough A, Dimitriou G, et al. Chronic respiratory morbidity following premature delivery--prediction by prolonged respiratory support requirement? Eur J Pediatr 1999; 158:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/54\">",
"      Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet 2006; 367:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/55\">",
"      Halvorsen T, Skadberg BT, Eide GE, et al. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr 2004; 93:1294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/56\">",
"      Doyle LW, Olinsky A, Faber B, Callanan C. Adverse effects of smoking on respiratory function in young adults born weighing less than 1000 grams. Pediatrics 2003; 112:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/57\">",
"      Halvorsen T, Skadberg BT, Eide GE, et al. Better care of immature infants; has it influenced long-term pulmonary outcome? Acta Paediatr 2006; 95:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/58\">",
"      Anand D, Stevenson CJ, West CR, Pharoah PO. Lung function and respiratory health in adolescents of very low birth weight. Arch Dis Child 2003; 88:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/59\">",
"      Palta M, Sadek-Badawi M, Sheehy M, et al. Respiratory symptoms at age 8 years in a cohort of very low birth weight children. Am J Epidemiol 2001; 154:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/60\">",
"      Pianosi PT, Fisk M. Cardiopulmonary exercise performance in prematurely born children. Pediatr Res 2000; 47:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/61\">",
"      Kilbride HW, Gelatt MC, Sabath RJ. Pulmonary function and exercise capacity for ELBW survivors in preadolescence: effect of neonatal chronic lung disease. J Pediatr 2003; 143:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/62\">",
"      Allen JL, Panitch HB. Lung function testing: chronic lung disease of infancy. Pediatr Pulmonol 2001; Suppl 23:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/63\">",
"      Baraldi E, Bonetto G, Zacchello F, Filippone M. Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation. Am J Respir Crit Care Med 2005; 171:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/64\">",
"      Aukland SM, Halvorsen T, Fosse KR, et al. High-resolution CT of the chest in children and young adults who were born prematurely: findings in a population-based study. AJR Am J Roentgenol 2006; 187:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/65\">",
"      Yuksel B, Greenough A. Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up. Thorax 1992; 47:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/66\">",
"      Chan KN, Silverman M. Increased airway responsiveness in children of low birth weight at school age: effect of topical corticosteroids. Arch Dis Child 1993; 69:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/67\">",
"      Pelkonen AS, Hakulinen AL, Hallman M, Turpeinen M. Effect of inhaled budesonide therapy on lung function in schoolchildren born preterm. Respir Med 2001; 95:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/68\">",
"      Panitch HB, Keklikian EN, Motley RA, et al. Effect of altering smooth muscle tone on maximal expiratory flows in patients with tracheomalacia. Pediatr Pulmonol 1990; 9:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/69\">",
"      Bush A, Busst CM, Knight WB, et al. Changes in pulmonary circulation in severe bronchopulmonary dysplasia. Arch Dis Child 1990; 65:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/70\">",
"      Hislop AA, Haworth SG. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990; 9:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/71\">",
"      Abman SH. The dysmorphic pulmonary circulation in bronchopulmonary dysplasia: a growing story. Am J Respir Crit Care Med 2008; 178:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/72\">",
"      Kinsella JP, Abman SH. Inhaled nitric oxide in the premature newborn. J Pediatr 2007; 151:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/73\">",
"      Balasubramaniam V, Mervis CF, Maxey AM, et al. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007; 292:L1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/74\">",
"      Mourani PM, Ivy DD, Rosenberg AA, et al. Left ventricular diastolic dysfunction in bronchopulmonary dysplasia. J Pediatr 2008; 152:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/75\">",
"      Tomashefski JF Jr, Oppermann HC, Vawter GF, Reid LM. Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol 1984; 2:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/76\">",
"      Khemani E, McElhinney DB, Rhein L, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007; 120:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/77\">",
"      Subhedar NV, Shaw NJ. Changes in pulmonary arterial pressure in preterm infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2000; 82:F243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/78\">",
"      Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 2002; 87:F15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/79\">",
"      Benatar A, Clarke J, Silverman M. Pulmonary hypertension in infants with chronic lung disease: non-invasive evaluation and short term effect of oxygen treatment. Arch Dis Child Fetal Neonatal Ed 1995; 72:F14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/80\">",
"      Mourani PM, Sontag MK, Younoszai A, et al. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008; 121:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/81\">",
"      Ascher DP, Rosen P, Null DM, et al. Systemic to pulmonary collaterals mimicking patent ductus arteriosus in neonates with prolonged ventilatory courses. J Pediatr 1985; 107:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/82\">",
"      Bhutani VK, Rubenstein SD, Shaffer TH. Pressure--volume relationships of tracheae in fetal newborn and adult rabbits. Respir Physiol 1981; 43:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/83\">",
"      Burnard ED, et al. Pulmonary insufficiency in prematurity. Aust Paediatr J 1965; 1:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/84\">",
"      CROTEAU JR, COOK CD. Volume-pressure and length-tension measurements in human tracheal and bronchial segments. J Appl Physiol 1961; 16:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/85\">",
"      Shaffer TH, Bhutani VK, Wolfson MR, et al. In vivo mechanical properties of the developing airway. Pediatr Res 1989; 25:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/86\">",
"      Miller RW, Woo P, Kellman RK, Slagle TS. Tracheobronchial abnormalities in infants with bronchopulmonary dysplasia. J Pediatr 1987; 111:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/87\">",
"      Radford PJ, Stillwell PC, Blue B, Hertel G. Aspiration complicating bronchopulmonary dysplasia. Chest 1995; 107:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/88\">",
"      Jacobs IN, Wetmore RF, Tom LW, et al. Tracheobronchomalacia in children. Arch Otolaryngol Head Neck Surg 1994; 120:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/89\">",
"      McCoy KS, Bagwell CE, Wagner M, et al. Spirometric and endoscopic evaluation of airway collapse in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1992; 14:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/90\">",
"      McCubbin M, Frey EE, Wagener JS, et al. Large airway collapse in bronchopulmonary dysplasia. J Pediatr 1989; 114:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/91\">",
"      Panitch HB, Allen JL, Alpert BE, Schidlow DV. Effects of CPAP on lung mechanics in infants with acquired tracheobronchomalacia. Am J Respir Crit Care Med 1994; 150:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/92\">",
"      Cohn RC, Kercsmar C, Dearborn D. Safety and efficacy of flexible endoscopy in children with bronchopulmonary dysplasia. Am J Dis Child 1988; 142:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/93\">",
"      Bhutani VK, Ritchie WG, Shaffer TH. Acquired tracheomegaly in very preterm neonates. Am J Dis Child 1986; 140:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/94\">",
"      Downing GJ, Kilbride HW. Evaluation of airway complications in high-risk preterm infants: application of flexible fiberoptic airway endoscopy. Pediatrics 1995; 95:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/95\">",
"      Fan LL, Flynn JW, Pathak DR. Risk factors predicting laryngeal injury in intubated neonates. Crit Care Med 1983; 11:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/96\">",
"      Fan LL, Flynn JW, Pathak DR, Madden WA. Predictive value of stridor in detecting laryngeal injury in extubated neonates. Crit Care Med 1982; 10:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/97\">",
"      Jones R, Bodnar A, Roan Y, Johnson D. Subglottic stenosis in newborn intensive care unit graduates. Am J Dis Child 1981; 135:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/98\">",
"      Joshi VV, Mandavia SG, Stern L, Wiglesworth FW. Acute lesions induced by endotracheal intubation. Occurrence in the upper respiratory tract of newborn infants with respiratory distress syndrome. Am J Dis Child 1972; 124:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/99\">",
"      Parkin JL, Stevens MH, Jung AL. Acquired and congenital subglottic stenosis in the infant. Ann Otol Rhinol Laryngol 1976; 85:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/100\">",
"      Rasche RF, Kuhns LR. Histopathologic changes in airway mucosa of infants after endotracheal intubation. Pediatrics 1972; 50:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/101\">",
"      Ratner I, Whitfield J. Acquired subglottic stenosis in the very-low-birth-weight infant. Am J Dis Child 1983; 137:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/102\">",
"      Sherman JM, Lowitt S, Stephenson C, Ironson G. Factors influencing acquired subgottic stenosis in infants. J Pediatr 1986; 109:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/103\">",
"      Strong RM, Passy V. Endotracheal intubation. Complications in neonates. Arch Otolaryngol 1977; 103:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/104\">",
"      Greenholz SK, Hall RJ, Lilly JR, Shikes RH. Surgical implications of bronchopulmonary dysplasia. J Pediatr Surg 1987; 22:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/105\">",
"      Grylack LJ, Anderson KD. Diagnosis and treatment of traumatic granuloma in tracheobronchial tree of newborn with history of chronic intubation. J Pediatr Surg 1984; 19:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/106\">",
"      Hauft SM, Perlman JM, Siegel MJ, Muntz HR. Tracheal stenosis in the sick premature infant. Clinical and radiologic features. Am J Dis Child 1988; 142:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/107\">",
"      Miller KE, Edwards DK, Hilton S, et al. Acquired lobar emphysema in premature infants with bronchopulmonary dysplasia: an iatrogenic disease? Radiology 1981; 138:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/108\">",
"      Nagaraj HS, Shott R, Fellows R, Yacoub U. Recurrent lobar atelectasis due to acquired bronchial stenosis in neonates. J Pediatr Surg 1980; 15:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/109\">",
"      Bailey C, Kattwinkel J, Teja K, Buckley T. Shallow versus deep endotracheal suctioning in young rabbits: pathologic effects on the tracheobronchial wall. Pediatrics 1988; 82:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/110\">",
"      Hodge D. Endotracheal suctioning and the infant: a nursing care protocol to decrease complications. Neonatal Netw 1991; 9:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/111\">",
"      Landa JF, Kwoka MA, Chapman GA, et al. Effects of suctioning on mucociliary transport. Chest 1980; 77:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/112\">",
"      Runton N. Suctioning artificial airways in children: appropriate technique. Pediatr Nurs 1992; 18:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/113\">",
"      Durand M, McEvoy C, MacDonald K. Spontaneous desaturations in intubated very low birth weight infants with acute and chronic lung disease. Pediatr Pulmonol 1992; 13:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/114\">",
"      Garg M, Kurzner SI, Bautista DB, Keens TG. Clinically unsuspected hypoxia during sleep and feeding in infants with bronchopulmonary dysplasia. Pediatrics 1988; 81:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/115\">",
"      McEvoy C, Durand M, Hewlett V. Episodes of spontaneous desaturations in infants with chronic lung disease at two different levels of oxygenation. Pediatr Pulmonol 1993; 15:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/116\">",
"      Sekar KC, Duke JC. Sleep apnea and hypoxemia in recently weaned premature infants with and without bronchopulmonary dysplasia. Pediatr Pulmonol 1991; 10:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/117\">",
"      Zinman R, Blanchard PW, Vachon F. Oxygen saturation during sleep in patients with bronchopulmonary dysplasia. Biol Neonate 1992; 61:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/118\">",
"      Harris MA, Sullivan CE. Sleep pattern and supplementary oxygen requirements in infants with chronic neonatal lung disease. Lancet 1995; 345:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/119\">",
"      Scher MS, Richardson GA, Salerno DG, et al. Sleep architecture and continuity measures of neonates with chronic lung disease. Sleep 1992; 15:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/120\">",
"      Greenspan JS, Wolfson MR, Locke RG, et al. Increased respiratory drive and limited adaptation to loaded breathing in bronchopulmonary dysplasia. Pediatr Res 1992; 32:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/121\">",
"      Teague WG, Pian MS, Heldt GP, Tooley WH. An acute reduction in the fraction of inspired oxygen increases airway constriction in infants with chronic lung disease. Am Rev Respir Dis 1988; 137:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/122\">",
"      Loughlin GM, Allen RP, Pyzik P. Sleep-related hypoxemia in children with bronchopulmonary dysplasia (BPD) and adequate oxygen saturation awake. Sleep 1987; 16:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/123\">",
"      Gaultier C, Praud JP, Cl&eacute;ment A, et al. Respiration during sleep in children with COPD. Chest 1985; 87:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/124\">",
"      Goldman MD, Pagani M, Trang HT, et al. Asynchronous chest wall movements during non-rapid eye movement and rapid eye movement sleep in children with bronchopulmonary dysplasia. Am Rev Respir Dis 1993; 147:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/125\">",
"      Praud JP, Cavailloles F, Boulhadour K, et al. Radionuclide evaluation of cardiac function during sleep in children with bronchopulmonary dysplasia. Chest 1991; 100:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/126\">",
"      Filtchev SI, Curzi-Dascalova L, Spassov L, et al. Heart rate variability during sleep in infants with bronchopulmonary dysplasia. Effects of mild decrease in oxygen saturation. Chest 1994; 106:1711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/127\">",
"      Hibbs AM, Johnson NL, Rosen CL, et al. Prenatal and neonatal risk factors for sleep disordered breathing in school-aged children born preterm. J Pediatr 2008; 153:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/128\">",
"      Moyer-Mileur LJ, Nielson DW, Pfeffer KD, et al. Eliminating sleep-associated hypoxemia improves growth in infants with bronchopulmonary dysplasia. Pediatrics 1996; 98:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/129\">",
"      Greenough A, Giffin FJ, Y&uuml;ksel B, Dimitriou G. Respiratory morbidity in young school children born prematurely--chronic lung disease is not a risk factor? Eur J Pediatr 1996; 155:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/130\">",
"      Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 2003; 88:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/131\">",
"      Greenough A, Alexander J, Boit P, et al. School age outcome of hospitalisation with respiratory syncytial virus infection of prematurely born infants. Thorax 2009; 64:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/132\">",
"      Tay-Uyboco JS, Kwiatkowski K, Cates DB, et al. Hypoxic airway constriction in infants of very low birth weight recovering from moderate to severe bronchopulmonary dysplasia. J Pediatr 1989; 115:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/133\">",
"      Abman SH, Wolfe RR, Accurso FJ, et al. Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 1985; 75:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/134\">",
"      Halliday HL, Dumpit FM, Brady JP. Effects of inspired oxygen on echocardiographic assessment of pulmonary vascular resistance and myocardial contractility in bronchopulmonary dysplasia. Pediatrics 1980; 65:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/135\">",
"      Balfour-Lynn IM, Field DJ, Gringras P, et al. BTS guidelines for home oxygen in children. Thorax 2009; 64 Suppl 2:ii1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/136\">",
"      Groothuis JR, Rosenberg AA. Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia. Am J Dis Child 1987; 141:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/137\">",
"      Singer L, Martin RJ, Hawkins SW, et al. Oxygen desaturation complicates feeding in infants with bronchopulmonary dysplasia after discharge. Pediatrics 1992; 90:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/40/17034/abstract/138\">",
"      Sherman JM, Davis S, Albamonte-Petrick S, et al. Care of the child with a chronic tracheostomy. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161:297.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6379 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-1201EFFE29-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17034=[""].join("\n");
var outline_f16_40_17034=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PULMONARY FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pulmonary function testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Late infancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Childhood",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Long-term changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Classic BPD",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - New BPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ASTHMA-LIKE SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PULMONARY ARTERY HYPERTENSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Natural history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Doppler echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      CENTRAL AND UPPER AIRWAY DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Acquired tracheobronchomalacia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Glottic and subglottic damage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Tracheal and bronchial stenosis and granuloma formation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SLEEP HYPOXEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      RESPIRATORY INFECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      IMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Oxygen therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Tracheostomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Cardiorespiratory monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Acute respiratory illness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Care setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/61/21464?source=related_link\">",
"      Assessment of stridor in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/29/11738?source=related_link\">",
"      Care of the neonatal intensive care unit graduate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29114?source=related_link\">",
"      Congenital anomalies of the intrathoracic airways and tracheoesophageal fistula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/58/41895?source=related_link\">",
"      Control of secondhand smoke exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/38/44649?source=related_link\">",
"      Evaluation of suspected obstructive sleep apnea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23912?source=related_link\">",
"      Growth management in preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15753?source=related_link\">",
"      Management of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25398?source=related_link\">",
"      Outcome of infants with bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29112?source=related_link\">",
"      Overview of pulmonary function testing in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18793?source=related_link\">",
"      Pathogenesis and clinical features of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27880?source=related_link\">",
"      Prevention of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/42/18088?source=related_link\">",
"      Tracheomalacia and tracheobronchomalacia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/58/21414?source=related_link\">",
"      Use of home cardiorespiratory monitors in infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_40_17035="Dx Legionella";
var content_f16_40_17035=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69022&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69022&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic tests for Legionella species",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Test characteristic",
"       </td>",
"       <td class=\"subtitle1\">",
"        Culture",
"       </td>",
"       <td class=\"subtitle1\">",
"        Urine antigen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Strains detected",
"       </td>",
"       <td>",
"        All species and serogroups",
"       </td>",
"       <td>",
"        Detects only L. pneumophila, serogroup 1; this accounts",
"for 70 to 80 percent of cases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Speed to results",
"       </td>",
"       <td>",
"        &ge;3",
"days",
"       </td>",
"       <td>",
"        15 minutes with some assays",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Technical demands",
"       </td>",
"       <td>",
"        Difficult - high rates of false negatives",
"       </td>",
"       <td>",
"        Easy - Rare false negatives except with strains other",
"than L. pneumophila, serogroup 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overall sensitivity",
"       </td>",
"       <td>",
"        &lt;10 to 80 percent",
"       </td>",
"       <td>",
"        70 to 80 precent*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Overall specificity",
"       </td>",
"       <td>",
"        100 percent",
"       </td>",
"       <td>",
"        &gt;99 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     * Helbig JH, Uldum, SA, Bernander, S, et al. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease. J Clin Microbiol 2003; 41:838.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17035=[""].join("\n");
var outline_f16_40_17035=null;
var title_f16_40_17036="ACC AHA ETT post revasculariz";
var content_f16_40_17036=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Exercise testing* before and after revascularization",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class I - There is evidence and/or general agreement that exercise testing before and after revascularization should be performed in the following settings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; To demonstrate ischemia before revascularization.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; To evaluate recurrent symptoms suggesting ischemia after revascularization.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIa - The weight of evidence or opinion is in favor of benefit from exercise testing before and after revascularization in the following setting:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; After discharge, to assist in activity counseling and/or exercise training as part of cardiac rehabilitation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIb - The evidence or opinion is less well established that exercise testing before and after revascularization is beneficial in the following settings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; To detect restenosis in selected high-risk asymptomatic patients within the first 12 months after percutaneous coronary intervention (PCI).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; Periodic monitoring of selected, high-risk asymptomatic patients to detect tenosis, graft occlusion, incomplete coronary revascularization, or disease progression. High risk includes patients with decreased left ventricular function, multivessel or proximal left anterior descending disease, a suboptimal PCI results, diabetes, prior sudden death, or a hazardous occupation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class III - There is evidence that exercise testing before and after revascularization is not useful and may be harmful in the following settings:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; To localize ischemia to determine the site of intervention.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull;&nbsp; For routine, periodic monitoring of asymptomatic patients after PCI or coronary artery bypass grafting.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Because of the relatively low sensitivity with exercise ECG testing (due in part to the high prevalence of single vessel disease), exercise stress imaging with SPECT or echocardiography is preferred.",
"    </div>",
"    <div class=\"reference\">",
"     From Gibbons, RJ, Balady, GJ, Bricker, JT, et al. ACC/AHA 2002 Guideline Update for Exercise Testing: a report of the American College of Cardiology/American Heart Association Task Force on practice Guidelines (Committee on Exercise Testing). Circulation 2002; 106:1883.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17036=[""].join("\n");
var outline_f16_40_17036=null;
var title_f16_40_17037="Gene defects renal malformation";
var content_f16_40_17037=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Human gene mutations associated with defects in renal morphogenesis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Primary disease",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gene",
"       </td>",
"       <td class=\"subtitle1\">",
"        Kidney phenotype",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alagille syndrome",
"       </td>",
"       <td>",
"        <em>",
"         JAGGED1",
"        </em>",
"       </td>",
"       <td>",
"        Cystic dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Apert syndrome",
"       </td>",
"       <td>",
"        <em>",
"         FGFR2",
"        </em>",
"       </td>",
"       <td>",
"        Hydronephrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bardet-Biedl syndrome",
"       </td>",
"       <td>",
"        <em>",
"         BBS1",
"        </em>",
"       </td>",
"       <td>",
"        Cystic dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beckwith-Wiedemann syndrome",
"       </td>",
"       <td>",
"        Dysregulation of imprinting in chromosome 11p15.5",
"       </td>",
"       <td>",
"        Medullary dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Branchio-Oto-Renal syndrome (BOR)",
"       </td>",
"       <td>",
"        <em>",
"         EYA1, SIX1, SIX5",
"        </em>",
"       </td>",
"       <td>",
"        Unilateral/bilateral agenesis/dysplasia, hypoplasia, collecting system anomalies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Campomelic dysplasia",
"       </td>",
"       <td>",
"        <em>",
"         SOX9",
"        </em>",
"       </td>",
"       <td>",
"        Dysplasia, hydronephrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fraser syndrome",
"       </td>",
"       <td>",
"        <em>",
"         FRAS1",
"        </em>",
"       </td>",
"       <td>",
"        Agenesis, dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoparathyroidism, sensorineural deafness, and renal anomalies (HDR)",
"       </td>",
"       <td>",
"        <em>",
"         GATA3",
"        </em>",
"       </td>",
"       <td>",
"        Dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kallmann syndrome",
"       </td>",
"       <td>",
"        <em>",
"         KAL1",
"        </em>",
"       </td>",
"       <td>",
"        Agenesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mammary-Ulnar syndrome",
"       </td>",
"       <td>",
"        <em>",
"         TBX3",
"        </em>",
"       </td>",
"       <td>",
"        Dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meckel Gruber syndrome",
"       </td>",
"       <td>",
"        MKS1, MKS3, NPHP6, NPHP8",
"       </td>",
"       <td>",
"        Cystic dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nephronopthisis",
"       </td>",
"       <td>",
"        <em>",
"         CEP290, GLIS2, RPGRIP1L, NEK8, SDCCAG8, TMEM 67, TTC21B",
"        </em>",
"       </td>",
"       <td>",
"        Cystic dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Okihiro syndrome",
"       </td>",
"       <td>",
"        <em>",
"         SALL4",
"        </em>",
"       </td>",
"       <td>",
"        Unilateral agenesis, VUR, malrotation, cross fused ectopia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pallister-Hall syndrome",
"       </td>",
"       <td>",
"        <em>",
"         GLI3",
"        </em>",
"       </td>",
"       <td>",
"        Agenesis, dysplasia, hydronephrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal Coloboma syndrome",
"       </td>",
"       <td>",
"        <em>",
"         PAX2",
"        </em>",
"       </td>",
"       <td>",
"        Hypoplasia, VUR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal hypoplasia, isolated",
"       </td>",
"       <td>",
"        <em>",
"         BMP4, RET",
"        </em>",
"       </td>",
"       <td>",
"        Hypoplasia, VUR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal tubular dysgenesis",
"       </td>",
"       <td>",
"        Renin, angiotensinogen, ACE, AT1 receptor",
"       </td>",
"       <td>",
"        Tubular dysgenesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rubinstein-Taybi syndrome",
"       </td>",
"       <td>",
"        <em>",
"         CREBBP",
"        </em>",
"       </td>",
"       <td>",
"        Agenesis, hypoplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Simpson-Golabi Behmel syndrome",
"       </td>",
"       <td>",
"        <em>",
"         GPC3",
"        </em>",
"       </td>",
"       <td>",
"        Medullary dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Townes-Brock syndrome",
"       </td>",
"       <td>",
"        <em>",
"         SALL1",
"        </em>",
"       </td>",
"       <td>",
"        Hypoplasia, dysplasia, VUR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zellweger syndrome",
"       </td>",
"       <td>",
"        <em>",
"         PEX1",
"        </em>",
"       </td>",
"       <td>",
"        Cystic dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Smith-Lemli-Opitz syndrome",
"       </td>",
"       <td>",
"        <em>",
"         DHCR7",
"        </em>",
"       </td>",
"       <td>",
"        Renal hypoplasia, cysts, and aplasia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ACE: angiotensin converting enzyme; AT1: angiotensin II receptor; VUR: vesicoureteral reflux.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17037=[""].join("\n");
var outline_f16_40_17037=null;
var title_f16_40_17038="Mucocutaneous bleeding children";
var content_f16_40_17038=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F82633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F82633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 511px\">",
"   <div class=\"ttl\">",
"    Diagnostic approach to a patient with mucocutaneous bleeding (purpuric disorders)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 491px; height: 267px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ITP: immune&nbsp;thrombocytopenia (previously known as idiopathic thrombocytopenic purpura); vWD: von Willebrand disease.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17038=[""].join("\n");
var outline_f16_40_17038=null;
var title_f16_40_17039="Algorithm gallbladder polyps";
var content_f16_40_17039=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73510&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73510&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 569px\">",
"   <div class=\"ttl\">",
"    A suggested algorithm for managing gallbladder polyps",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 549px; height: 495px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Symptoms: Biliary type pain, common duct obstruction, cholangitis, or recurrent pancreatitis. Dyspepsia is not an indication for surgery.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_40_17039=[""].join("\n");
var outline_f16_40_17039=null;
